Placental function estimated by T2*-weighted magnetic resonance imaging by Sinding, Marianne Munk
 
  
 
Aalborg Universitet
Placental function estimated by T2*-weighted magnetic resonance imaging
Sinding, Marianne Munk
DOI (link to publication from Publisher):
10.5278/vbn.phd.med.00094
Publication date:
2017
Document Version
Publisher's PDF, also known as Version of record
Link to publication from Aalborg University
Citation for published version (APA):
Sinding, M. M. (2017). Placental function estimated by T2*-weighted magnetic resonance imaging. Aalborg
Universitetsforlag. Ph.d.-serien for Det Sundhedsvidenskabelige Fakultet, Aalborg Universitet
https://doi.org/10.5278/vbn.phd.med.00094
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
            ? Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
            ? You may not further distribute the material or use it for any profit-making activity or commercial gain
            ? You may freely distribute the URL identifying the publication in the public portal ?
Take down policy
If you believe that this document breaches copyright please contact us at vbn@aub.aau.dk providing details, and we will remove access to
the work immediately and investigate your claim.
Downloaded from vbn.aau.dk on: November 30, 2020
M
A
R
IA
N
N
E M
U
N
K
 SIN
D
IN
G
PLA
C
EN
TA
L FU
N
C
TIO
N
 ESTIM
ATED
 B
Y T2*-W
EIG
H
TED
 M
A
G
N
ETIC
 R
ESO
N
A
N
C
E IM
A
G
IN
G
PLACENTAL FUNCTION ESTIMATED
BY T2*-WEIGHTED MAGNETIC
RESONANCE IMAGING
BY
MARIANNE MUNK SINDING
DISSERTATION SUBMITTED 2017
 
 
PLACENTAL FUNCTION ESTIMATED 
BY T2*-WEIGHTED MAGNETIC 
RESONANCE IMAGING 
 
PhD Thesis 
Marianne Munk Sinding 
 
March 2017 
 
. 
  
Dissertation submitted: March 17, 2017
PhD supervisor:  Ole B. Christiansen, Professor, MD, DMSc
   Department of Obstetrics and Gynecology
   Aalborg University Hospital, Aalborg, Denmark
Assistant PhD supervisors: Anne N. W. Sørensen, Clinical associate Professor,   
   MD, PhD
   Department of Obstetrics and Gynecology
   Aalborg University Hospital, Aalborg, Denmark
   Niels Uldbjerg, Professor, MD, DMSc
   Department of Obstetrics and Gynecology
   Aarhus University Hospital, Skejby, Denmark
   David A. Peters, MSc, PhD
   Department of Clinical Engineering
   Central Region, Denmark
PhD committee:  Ulla Weinrich, Clinical Associate Professor (MD, PhD)
   Aalborg University/Aalborg University Hospital,   
   Denmark
   Professor Ganesh Acharya (MD, PhD, FRCOG)
   Karolinska Institutet, Sweden
   Ed Johnstone, Clinical Senior Lecturer and Consultant
   (MBChB, PhD, MRCOG)
   University of Manchester, UK
PhD Series: Faculty of Medicine, Aalborg University
ISSN (online): 2246-1302
ISBN (online): 978-87-7112-919-9
Published by:
Aalborg University Press
Skjernvej 4A, 2nd floor
DK – 9220 Aalborg Ø
Phone: +45 99407140
aauf@forlag.aau.dk
forlag.aau.dk
© Copyright: Marianne Munk Sinding
Printed in Denmark by Rosendahls, 2017
3 
ENGLISH SUMMARY 
Placental dysfunction is associated with adverse neonatal outcomes including low 
birth weight. Prenatal identification of placental dysfunction improves the neonatal 
outcomes and therefore, in vivo markers of placental dysfunction is of high clinical 
interest. One approach could be the detection of placental hypoxia, which may be 
associated to placental dysfunction, using T2*-weighted Magnetic Resonance 
Imaging (MRI). The placental MRI transverse relaxation time, T2*, reflects tissue 
oxygenation as the presence of deoxyhemoglobin affects the spins of protons thereby 
creating magnetic field inhomogeneities, which reduce the T2* value. Thus in hypoxic 
tissue, the T2* value is reduced. Placental Blood Oxygen Level Dependent (BOLD) 
MRI is a T2*-weighted sequence, in which signal changes are closely correlated to 
changes in tissue hemoglobin saturation during oxygen-challenge. Therefore, the aim 
of this project was to investigate the feasibility of T2*-weighted MRI (T2* 
measurements and BOLD MRI) as non-invasive methods for the detection of 
placental hypoxia and thereby placental dysfunction. 
In this project, we demonstrated that in normal pregnancies, the placental T2* value 
is reduced as pregnancy advances and in pregnancies complicated by placental 
dysfunction, the placental T2* value is lower (Study I). In the same study, we assessed 
the reproducibility of the T2* method and found it to be reasonable robust. In Study 
IV, we revealed strong correlations between placental T2* value and placental 
perfusion estimated by Doppler ultrasound uterine artery (UtA) pulsatility index (PI) 
between 20 and 40 weeks’ gestation and subsequent birth weight percentiles. The T2* 
value performed significantly better than the UtA PI in the prediction of low birth 
weight. Using the BOLD sequence, we demonstrated that in normal pregnancies, the 
placental BOLD signal increases significantly during maternal oxygen-challenge and 
in placental dysfunction, the BOLD response is altered (Study II). In contrast to the 
T2* measurements, the BOLD response can only be measured in relative values as 
the baseline signals vary among individuals. Therefore, in order to interpret the 
oxygen-challenge relative BOLD response, we used placental T2* values as markers 
of placental baseline conditions and absolute changes in placental oxygenation. We 
concluded that in placental dysfunction, a high BOLD response is caused merely by 
altered baseline conditions rather than a larger increase in placental oxygenation 
compared to normal (Study V). Using the BOLD sequence, we also investigated 
spontaneous uterine contractions. We found that uterine contractions occur regularly 
in normal pregnancies and that they have a major impact on placental oxygenation, 
which needs to be considered when interpreting placental MRIs (Study III).  
In conclusion, placental T2*-weighted imaging has the potential to detect placental 
dysfunction in vivo and therefore, the methods deserves further investigations. The 
perspective may be a clinical tool to be used in the risk stratification of pregnant 
women. 
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DANSK RESUME  
Placenta dysfunktion er associeret til dårligt neonatal udkomme herunder lav 
fødselsvægt. Prænatal identifikation af placenta dysfunktion kan bedre det neonatale 
udkomme og derfor er udviklingen af in vivo markører for placenta-dysfunktion af 
høj klinisk interesse. En mulig markør kunne være placenta hypoxi, som er associeret 
til placenta dysfunktion. Placenta hypoxi kan potentielt detekteres ved hjælp af T2*-
vægtet Magnetisk Resonans (MR) scanning. Den transverselle relaxations-tid, T2*, 
afspejler vævsoxygenering, idet paramagnetisk deoxyghemoglobin påvirker spinnene 
i naboprotoner og dermed skabes inhomogeniteter i det magnetiske felt, hvilket 
reducerer vævets T2* værdi. T2* værdien er således reduceret i hypoxisk væv. Blood 
oxygen level dependent (BOLD) MR er en T2*-vægtet sekvens, der er følsom overfor 
ændringer i saturation under ilt-test. Formålet med dette projekt var derfor at 
undersøge om T2*-vægtet MR (T2* måling og BOLD sekvens) kan bruges som in 
vivo markør for placenta hypoxi og dermed for placenta dysfunktion. 
I dette projekt fandt vi, at placenta T2* værdien falder med gestationsalderen i 
ukomplicerede graviditeter og at T2* værdien er signifikant reduceret i graviditeter 
kompliceret af placenta dysfunktion (Studie I). I samme studie undersøgte vi 
reproducerbarheden af T2* metoden og fandt at metoden er robust. I studie IV fandt 
vi en stærk korrelation mellem placenta T2* værdien og placenta perfusionen vurderet 
ud fra ultralyd Doppler pulsatilitet indeks (PI) i arteria uterina (UtA) i gestationsuge 
20 til 40 og senere fødselsvægt. Vi fandt ligeledes at T2* værdien var en stærkere 
prædiktor for lav fødselsvægt end UtA PI. 
Ved hjælp af BOLD MR sekvensen, fandt vi at placenta BOLD signalet stiger 
signifikant under maternel ilt-test i ukomplicerede graviditeter og at BOLD responset 
i graviditeter kompliceret af placenta dysfunktion er ændret (Studie II). I modsætning 
til T2* værdien kan BOLD responset kun måles i relative værdier. Derfor undersøgte 
vi BOLD responset ud fra absolutte normoxiske og hyperoxiske T2* værdier, og vi 
fandt at i graviditeter kompliceret af placenta dysfunktion afspejler et forhøjet BOLD 
respons blot et ændret udgangs-BOLD signal og ikke en større absolut stigning i 
placentas oxygenering sammenlignet med ukomplicerede graviditeter (Studie V). Vi 
undersøgte ligeledes spontane uterus kontraktioner under BOLD MR. Her fandt vi at 
spontane uterus kontraktioner er relativ hyppige og at de i høj grad påvirker placenta 
BOLD signalet og dermed placentas oxygenering. Det er således en meget væsentlig 
fejlkilde i T2*-vægtet MR scanning, som man i høj grad skal være opmærksom på, 
når placenta MR fortolkes.  
Vi konkluderer at T2*-vægtet MR scanning af placenta kan detektere placenta 
dysfunktion og at der derfor bør forskes mere i denne lovende metode. Perspektivet 
er en klinisk test til anvendelse ved risikostratificeringen af gravide.  
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CHAPTER 1. INTRODUCTION  
Placental dysfunction is associated to adverse pregnancy outcomes including fetal 
growth restriction (FGR), which may be defined as the failure of the fetus to reach its 
genetically growth potential (1). Most, but not all, FGR fetuses are small for 
gestational age (SGA) and placental dysfunction is the leading cause of FGR (2,3). It 
is a common condition affecting 5-10% of all pregnancies, depending on the definition 
used (4,5). Placental dysfunction may be classified into two phenotypes termed early-
onset and late-onset disease. These phenotypes are characterized by differences in 
gestational age at disease onset (diagnosis before or after 32-34 week’s gestation 
(6,7)), the association to preeclampsia (8), ultrasound Doppler findings and severity 
(7,9).  
In general, placental dysfunction is a progressive process in which the transfer of 
nutrients and oxygen to the developing fetus is impaired. This leads to various fetal 
compensatory adaptations and may progress towards circulatory failure and 
eventually fetal acidosis and fetal death (10,11). Therefore, growth restricted fetuses 
are at high risk of perinatal morbidity and mortality (12-15), and they have an 
increased risk of long term adverse outcomes including impaired neurological 
development (16,17), cardiovascular disease (18-25), and metabolic syndrome (26).  
Prenatal identification improves the perinatal morbidity and mortality through timely 
delivery and prompt neonatal care (27), whereas a false diagnosis of FGR is associated 
with higher rates of labor induction, caesarian sections and short-term adverse 
neonatal outcomes (28). Therefore, correct identification of these fetuses is of 
enormous importance in the prenatal care. Furthermore, identification of FGR fetuses 
has the potential to be used in the cardiovascular and metabolic disease risk 
stratification in adult life. Finally, the adverse effects highlight the need of ongoing 
research in the development of treatment and prevention of placental dysfunction. 
In modern obstetrics, detecting, diagnosing, and predicting placental dysfunction are 
major challenges due to several factors. The most important factor is that no clinical 
applicable direct measurement of placental function exists, and therefore, detection 
and surveillance of pregnancies complicated by placental dysfunction mostly rely on 
clinical assessments of fetal growth and fetal well-being rather than direct assessment 
of placental function. During the last decades, extensive research has been conducted 
in order to develop clinical methods to detect and predict placental dysfunction. These 
methods may include ultrasound Doppler measurements of the uterine artery (UtA), 
umbilical artery (UA), and the cerebroplacental ratio (CPR), and measurements of 
various angiogenetic factors, which together with maternal characteristics and fetal 
biometry have been combined into predictive models of low birth weight or other 
adverse outcomes associated to placental dysfunction. Nonetheless, several obstacles 
as described in this thesis may complicate these predictive models. Therefore, new 
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strategies are needed in order to detect placental dysfunction, and placental Magnetic 
Resonance Imaging (MRI) may be an option. As placental dysfunction may be 
associated to placental hypoxia (29), one approach is the T2*-weighted MR imaging, 
in which the MRI signal depends on the amount of tissue deoxyhemoglobin (30). 
Therefore, the aim of this project is to investigate the feasibility of T2*-weighted 
imaging as a non-invasive in vivo method for estimating placental hypoxia and 
thereby placental dysfunction.  
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CHAPTER 2. BACKGROUND 
This chapter contains four parts. The first part holds background information about 
the normal placenta including the placental structure, development, oxygen 
environment, and the placental oxygen transport capacity. The second part holds 
information about placental dysfunction and the related obstacles in clinical practice. 
The third and fourth parts represent background information for MRI of placental 
oxygenation, including a short presentation of the previous literature in the field and 
the ethical considerations regarding MRI in pregnancy. 
2.1. THE NORMAL PLACENTA 
The placenta has a wide range of function being a complex endocrine organ, playing 
a vital role in the transfer of oxygen and nutrients for the fetus, and acting as an 
immunological barrier between the mother and the fetus (31).  
2.1.1. PLACENTAL STRUCTURE 
The mature human placenta has a disc-shaped structure and consists of a fetal region 
(the chorionic plate) and a maternal region (the basal plate) surrounding the 
intervillous space (Figure 1). Maternal blood enters the intervillous space from the 
low-resistance spiral arteries and leaves back through the venous orifices in the basal 
plate. Within the intervillous space, the blood is dispersed through the vascularized 
fetal villous three, protruding from the chorionic plate. This arrangement of maternal 
and fetal blood compartments, in which the fetal blood is bathed by a fountain of 
maternal blood with various flow directions, is termed a multivillous system (32,33).  
Septae protrude from the basal plate into the intervillous spaces dividing the placenta 
into 15-20 maternal lobes, which can be seen on the maternal surface of the placenta. 
Each lobe is perfused by one or more spiral arteries and contains one or more fetal 
villous threes. At the placental margin, the intervillous space is degenerated (the 
marginal zone) and more peripheral, the chorionic plate and the basal plate fuse and 
form the chorion leave (34).  
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Figure 1. The mature human placenta. CP chorionic plate; BP basal plate; IVS intervillous 
space; P placental bed; M myometrium; CL chorion leave; A amnion; MZ marginal zone 
between placenta and fetal membranes; S placental septum; UC umbilical cord (From 
Kaufmann and Scheffen (35), with permission from publisher (Elsevier)). 
2.1.2. PLACENTAL DEVELOPMENT  
In early pregnancy, placentation begins with the implantation of the blastocyst at 
gestational day 6-7. The wall of the blastocyst contains an outer layer of trophoblast 
and an inner layer of extraembryonic mesoderm. The trophoblast cells start to migrate 
between the endometrial cells opening up the intercellular spaces, thereby enabling 
trophoblast protrusions to penetrate. During trophoblast protrusion, the trophoblast 
cells undergo transformation into syncytiotrophoblast, whereas remaining cells from 
the blastocyst wall are called the cytotrophoblast. The syncytiotrophoblast rapidly 
increases and forms a complete mantle around the blastocyst. At day 8th lacunae are 
formed within the syncytiotrophoblastic mass at the implantation pole. These lacunae 
are the precursor of the intervillous space and in the first trimester, they are filled with 
maternal plasma and secretions from endometrial glands. The cytotrophoblast then 
starts migrating within the trabecula between the lacunae, and eventually they 
penetrate the syncytiotrophoblast and spread laterally to form a layer between the 
syncytiotrophoblast mantle and the endometrium. Thereby three layers of the original 
blastocyst wall exist; 1) the primary chorionic plate facing the cavity of the blastocyst, 
2) the lacunar system and 3) the cytotrophoblast facing the endometrium (the initial 
basal plate) (36). At this stage the fetal villi starts to develop. Cytotrophoblast 
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proliferation causes side branches on the trabeculae to protrude into the lacunae, 
which is then transformed into the intervillous space. The branches are termed primary 
villi until they are invaded by mesenchymal tissue from the extraembryonic 
mesoderm, forming them into secondary villi. Vasculogensis within the secondary 
villi begins, and when the first fetoplacental capillaries are present, the villi are termed 
tertiary villi (3). Thus, at around the 21st day of gestation, the placenta is a vascularized 
villous organ. A population of the cytotrophoblast cells facing the endometrium in the 
initial basal plate differentiates and migrates deeper into the endometrium. This is the 
start of a very important process, known as the trophoblast invasion (37). The 
trophoblast cells invade into the maternal spiral arteries and form a plug in the lumen 
thereby preventing maternal blood to enter the intervillous space (38). At the end of 
the first trimester, the plugs in the spiral arteries disappear, and maternal blood enters 
the intervillous space. The trophoblast also induces vascular remodeling of the spiral 
arteries, which lose the smooth muscle in the walls and undergo dilation converting 
them into low-resistance vessels (39). This dilation is considered to be complete 
around 20-22 weeks’ gestation, whereas the villous trophoblast continues to develop 
throughout gestation (40). The tertiary villi develop and differentiate into other villous 
types, which results in an exponential increase of the total villi surface area and a 
progressive decrease in the thickness of the villous membrane (40,41). These changes 
increase the placental transfer capacity, thereby meeting the increasing metabolic 
demand from the fetus and the placenta itself.  
2.1.3. PLACENTAL OXYGEN ENVIRONMENT 
In early gestation, when the trophoblast plugs prohibit the maternal blood flow in the 
intervillous space, the placenta has a relatively low oxygen level with an oxygen 
partial pressure (pO2) around 20 mmHg (42-44). This relative hypoxic environment 
is needed to protect the early developing fetus from oxidative distress (45) and drives 
ongoing fetal angiogenesis (39). At the end of the first trimester, when the plugs in 
the spiral arteries disappear, and maternal blood enters the intervillous space, the pO2 
rises to around 50 mmHg (43,44,46). In vitro measurements of blood extracted from 
the intervillous space during cordocentesis performed in 16-20 weeks’ gestation (47) 
and during cordocentesis and cesarean section at 37-40 weeks gestation (47,48) have 
shown a decrease in placental pO2 as gestational age advances. Likewise, the placental 
oxygen saturation (sO2) declines from 66.9% at 13-16 weeks’ gestation (44) to 52.1% 
at 37-40 weeks’ gestation (48). This decreased sO2 of the intervillous space has also 
been demonstrated in normal pregnancies at 20 to 36 weeks’ gestation using near 
infrared spectroscopy, in which intervillous space oxygen indexes are used as proxies 
of intervillous space sO2 (49). The reduction in placental oxygenation can be 
explained by the increasing oxygen demand from the fetus and the placenta. The 
development of the intervillous pO2 throughout gestation is summarized in Figure 2. 
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Figure 2. The mean and 95% confidence intervals of oxygen partial pressure – dashed lines – 
throughout gestation in the intervillous space in the human. Values are derived from in vivo 
measurements reported by Rodech et al. (43), Soothill et al. (47,50) and Jauniaux et al 
(42,44,46) (from Zamudio et al.(51), with permission from publisher (Whiley online library)) 
The normal pO2 and sO2 of the umbilical and the uterine blood in the third trimester 
are presented in Table 1. 
 pO2 (mmHg) sO2 (%) 
Umbilical artery 20 40 
Umbilical vein 30 70 
Uterine artery 100 98-100 
Uterine vein 42 70 
Table 1. The normal pO2 and sO2 of the umbilical and the uterine blood in the third trimester 
(48,52,53). 
Within the intervillous space, oxygenation of the maternal blood entering from the 
spiral arteries decreases radially as the blood passes over the villous three and gas-
exchange takes place (illustrated in Figure 1 by red and blue arrows). This radial 
oxygen-gradient has been proposed in primates (54,55) and in the human placenta 
(56,57). It has also been visualized in human placental MRI studies using BOLD-
contrast (58,59), and moreover, it has been evidenced by a higher antioxidant activity 
in human central villi compared to peripheral once (60).  
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2.1.4. PLACENTAL OXYGEN TRANSPORT 
As presented in the beginning of this section, the placenta displays a wide range of 
function. In this thesis, focus will be on the transfer of oxygen from the mother to the 
fetus.  
The oxygen transport from the mother to the fetus is determined by the rates and 
patterns of maternal and fetal placental blood flows, the oxygen diffusing capacity of 
the placenta, and the oxygen capacities and affinities of fetal and maternal blood (61). 
It is generally accepted that the placental oxygen transfer predominantly occurs by 
simple diffusion, in which the driving force is the pO2 gradient between maternal 
blood in the intervillous space and fetal blood in the villi vessels (31). As described 
by the Ficks law, the simple diffusion of oxygen across the placenta per unit time is 
determined by the thickness and surface area of the membrane, the placental diffusion 
coefficient of oxygen and the pO2 difference between uteroplacental and fetoplacental 
blood (32). O2 is a small hydrophobic molecule, which diffuses readily across the 
membrane in normal placentas. Hence, as the driving pO2 gradient is maintained by 
flow within the uteroplacental and the fetoplacental compartments, the oxygen 
transfer is considered predominantly to be flow-limited (32,62,63). However, the 
observed differences between umbilical vein pO2 and the uterine vein pO2 in normal 
pregnancy (Table 1) might indicate that oxygen transport to some extend is also 
limited by the placental diffusion capacity. Nonetheless, other important factors may 
explain this pO2 difference. Firstly, besides supplying the fetus, the maternal arterial 
blood supplies the placenta, which has a high metabolic activity, and near term it 
consumes about 40% of the delivered oxygen. Even when the oxygen availability is 
reduced, placental oxygen consumption may be maintained at the expense of the fetus 
(64). Secondly, as the maternal and the fetal blood flow in a multivillous system, in 
which the fetal vascularized villi are bathed by a fountain of maternal blood with 
various flow directions, “shunts” may exist, in which maternal blood passes the 
intervillous space without being in direct contact with the villous tree. Moreover, 
maternal arteriovenous shunts located in the placental bed (65), fetal arteriovenous 
shunts (63) and uneven distributions of maternal and fetal blood flows to placental 
regions also allow blood to bypass areas of gas exchange (32,52,66,67). These 
nonhomogeneous flow patterns reduce the oxygen transport efficiency and they 
contribute to the mismatch between umbilical vein pO2 and the uterine vein pO2 in 
normal pregnancy.  In contrast, the passive oxygen diffusion across the placenta is 
enhanced by differences in hemoglobin oxygen affinities in the maternal and the fetal 
blood. The fetal hemoglobin (hemoglobin F) has a higher oxygen affinity than 
maternal hemoglobin (hemoglobin A) (68). Moreover, during gas-exchange the 
maternal blood receives carbon dioxide (CO2) from the fetal blood thereby increasing 
the maternal CO2 partial pressure (pCO2). Thereby, the pH of the maternal blood falls, 
which diminishes the oxygen affinity of maternal hemoglobin. Likewise, as pCO2 is 
reduced in the fetal blood, the pH rises, which further increases the oxygen affinity of 
the fetal hemoglobin (the Bohr effect) (63).  
PLACENTAL FUNCTION ESTIMATED BY T2*-WEIGHTED MAGNETIC RESONANCE IMAGING 
18
 
 
Throughout gestation, various adaptations occur in order to meet the increasing 
oxygen demand from the fetus. Firstly, the total placental size and the total uterine 
blood flow are increased (69). Uterine blood flow estimates are subjects to many 
errors; however, the uterine blood flow at term has recently been estimated to be 
around 800 ml/min or 270 ml/min/kg fetus (70). Although the total uterine blood flow 
is increased, the flow per unit mass of the placenta (placental perfusion) throughout 
gestation is a matter of debate. In 1960, Assali et al. (69) found the uterine blood flow 
per unit weight of pregnant uterus in a constant range between 9 and 40 weeks’ 
gestation. Nowadays, several studies have estimated the placental perfusion using 
MRI, but the results are varying. The inconsistencies can be explained by the use of 
different MRI sequences and the use of different regions of interests (ROI) covering 
the entire placenta or only the basal plate. One should also keep in mind that some 
MRI techniques do not measure perfusion in a classical manner (net blood flow 
through a tissue). Rather instead, they measure blood movement within the ROI. 
Nevertheless, this measurement may be functionally more relevant given the complex 
architecture of the maternal and fetal vascular network within the placenta, in which 
blood flows in various directions. Moreover, fetoplacental blood within the ROI may 
contribute to the MRI result. Some MRI studies report placental perfusion to stay 
relatively constant throughout gestation (71-74), whereas others have reported a 
slightly reduction in the placental perfusion fraction as gestational age advances 
(75,76). These latter studies are in line with a previous histological study on normal 
placentas reporting slightly reducing intervillous volume fractions as gestational 
advances (77). On the contrary, in a study using contrast-enhanced ultrasound in the 
macaques, the rate of perfusion within the intervillous space was increased from the 
mid-second to early third-trimester (78). Thus, changes in uteroplacental perfusion 
throughout gestation remain unclear. Nonetheless, these previous study might indicate 
that the perfusion remains in a relatively constant range. Another adaptation in order 
to meet the increasing demand from the fetus is the increasing placental diffusion 
capacity as the villous trophoblast surface area increases and the membrane thickness 
decreases. Moreover, the total umbilical blood flow is increased as gestational 
advances; however, the umbilical blood flow per unit fetus is decreased near term (79-
81), and so is the pO2 and the sO2 of the umbilical artery and vein (47,82,83). Even 
though that this decrease is compensated by an increasing fetal hemoglobin 
concentration in order to maintain the oxygen content relatively constant (47,82), the 
reduced umbilical blood flow per unit fetus has been proposed to contribute to an 
adverse intrauterine environment at the very end of gestation (79). 
 
2.2. PLACENTAL DYSFUNCTION 
Dysfunctional placentas are associated with altered blood flow in the uteroplacental 
circulation and/or in the fetoplacental circulation, altered placental morphology and 
altered molecular transport mechanisms (84). The major result of these alterations is 
reduced delivery of oxygen and nutrients to the fetus.  
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2.2.1. PLACENTAL PATHOLOGICAL FINDINGS 
The placental pathological findings associated to placental dysfunction may be 
classified into signs of maternal vascular malperfusion (MVM) and signs of fetal 
vascular malperfusion (FVM) (85). In both early-onset and late-onset disease, signs 
of MVM and FVM may be present at the same time. In early-onset disease, the 
pathological findings are typically more pronounced than in late-onset disease and 
they are mainly associated to MVM. Late-onset disease represents a more 
heterogeneous group (86) with an increasing incidence of pathological findings of 
MVM and FVM compared to normal pregnancy (87). Moreover, in particular the late-
onset cases may be even histological unremarkable (88,89). On the contrary, signs of 
MVM or FVM may be present in pregnancies with normal outcomes (90). In general, 
placental dysfunction is associated with a reduced villous volume, reduced villous 
surface area (91-93), increased thickness of the trophoblast (92,93), and malformed 
villous capillaries (94). In a recent workshop consensus statement, the placental 
diagnostic criteria including MVM and FVM were reviewed and agreed upon (85). 
According to this consensus statement, MVM include several cross morphological 
and microscopic changes. The former may include reduced placental weight (< 10th 
percentile), infarction (> 5%) and retroplacental hemorrhage, whereas the latter may 
include signs of distal villous hypoplasia (long, thin villi), accelerated villous 
maturation (small, short hypermature villi for gestational age) and decidual 
arteriopathy including for instance signs of abnormal spiral artery remodeling. Signs 
of FVM may be focal or global and may contain the presence of avascular villi with 
or without thrombi, fibrin deposition etc. Moreover, signs of villitis of unknown 
etiology may be associated to placental dysfunction (85). In this thesis, the term 
placental vascular malperfusion (PVM) refers to the presence of MVM and/or FVM. 
2.2.2. PLACENTAL BLOOD FLOWS 
A key aspect of the dysfunctional placenta is an impaired conversion of the spiral 
arteries into low-resistance vessels during early placentation. This impaired 
placentation is considered the main cause of placental dysfunction in FGR 
pregnancies as well as in other pregnancy complications such as preeclampsia, 
spontaneous preterm labor and late spontaneous abortion (95). It is generally accepted 
that impaired conversion of the spiral arteries limits the maternal blood flow into the 
intervillous space (96); however, controversies exists regarding the exact 
hemodynamic consequences of the impaired conversion. Mathematical and in silico 
models suggest that the impaired conversion of the spiral arteries results in a high-
pressure, high-velocity flow of maternal blood into the intervillous space creating 
turbulent intervillous flow, which may reduce the transport efficiency. Moreover, 
unstable intervillous flow with subsequent ischemia-reperfusion may induce oxidative 
damage (97,98). In one of the models, Burton et al. (97) also suggest that the total 
volume of maternal blood flowing to the placenta is not directly affected by the lack 
of spiral artery conversion. However, secondary changes within the spiral arteries, 
such as spiral artery atherotic changes and occlusions with infarction of the overlying 
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placental parenchyma, may restrict the uteroplacental blood flow (29,97) as evidenced 
by an increased UtA Doppler resistance (99).  
The impaired uteroplacental flow may lead to fetal stem vessel vasoconstriction and 
secondary villous maldevelopment with a subsequent increased resistance in the 
fetoplacental circulation (100), as evidenced by the increased UA Doppler resistance 
often observed in FGR pregnancies (99). The pathology underlying the early fetal 
stem vessel vasoconstriction is unclear. It may be a diminished maternal blood flow 
and decreased oxygenation in the intervillous space (101,102) or an initial hyperoxic 
environment (46). It has also been suggested that the stem vessel vasoconstriction is 
caused by high velocity-flow of the maternal blood in the center of the intervillous 
space causing perfusion damage of the villi (97,98) and malperfusion of the 
intervillous space as some blood may short-circle much of the villous three. The 
degree of malperfusion may explain the different types of secondary villous 
abnormalities. Thus, low-grade malperfusion may lead to a proliferative villous 
response (accelerated villous maturation) whereas high-grade malperfusion may lead 
to villous hypoplasia (103,104). Most often, a high UA Doppler resistance is caused 
by stem villus vasoconstriction and villous abnormalities secondary to uteroplacental 
malperfusion as described above. However, in some cases, the primary abnormality 
may be a primary defect in the terminal villous tree (105). This may explain why some 
FGR cases exhibit high UA Doppler resistance without abnormal UtA flow. In a 
recent study, it was demonstrated that such cases were delivered later compared to 
FGR cases with both abnormal UtA and UA Doppler findings, and that their placentas 
more often revealed massive perivillous fibrin deposition, chronic intervillositis, and 
choriangiosis, but significantly lower rates of MVM (106).  
2.2.3. THE OXYGEN ENVIRONMENT AND OXYGEN TRANSPORT   
Decades ago, in vivo cord blood sampling demonstrated that FGR is associated to 
fetal hypoxemia (82,107). Recently, fetal hypoxemia has also been demonstrated 
using T2-weighted MRI in late-onset disease (108). However, the cause of fetal 
hypoxemia is widely debated. In 1997, Kingdom and Kaufmann (96) proposed a 
model including three categories for the origin of fetal hypoxemia; 1) Preplacental 
hypoxia, in which the fetus and the placenta are hypoxic due to reduced oxygen 
content in the maternal blood (high altitude pregnancy or maternal anemia). 2) 
Uteroplacental hypoxia, in which the maternal blood has a normal oxygen content, 
but it is restricted to entry the intervillous space due to impaired conversion of spiral 
arteries or occlusions of the arteries. Thus, the fetus and the placenta are both hypoxic 
and 3) Postplacental hypoxia, in which oxygenation of the intervillous space is normal 
(or increased compared to normal), but impaired fetoplacental perfusion prohibits the 
transfer of oxygen to the fetus, a situation the authors also refer to as “placental 
hyperoxia”.  
It is generally assumed that the lack of spiral artery conversion leads to intervillous 
hypoxia (95,109,110). However, intervillous hypoxia has never been demonstrated in 
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pregnancies complicated by placental dysfunction. On favor of intervillous hypoxia 
is that in preeclampsia, placentas have been shown to have gene expression profiles 
consistent with hypoxia (111-113). Likewise, in angiotensin-converting enzyme 2 
(ACE2) knockout mice associated with small fetal size, uterine artery dysfunction is 
associated with higher levels of placental pimonidazole, a marker of hypoxia, and 
hypoxia-inducible factor-2α (114). Most likely, the secondary changes to impaired 
spiral artery conversion, including for instance acute spiral artery atherosis and 
thrombosis with infarction of the overlying placental parenchyma, have a major 
impact on intervillous blood flow resulting in local hypoxia-ischemia (29). This is in 
accordance with several MRI studies demonstrating reduced placental perfusion in 
pregnancies complicated by placental dysfunction (74,115-117).  In these studies, 
both changes in the maternal and the fetal compartment may contribute to the MRI 
findings and therefore, they do not only asses the uteroplacental perfusion. However, 
in support of reduced intervillous perfusion and thereby reduced oxygen delivery to 
the intervillous space is a study by Brunelli et al. (118) using dynamic contrast-
enhanced (DCE) MRI. Their results, retrospectively obtained from MRI examinations 
performed in order to exclude placental adhesive disorders, demonstrated significant 
intervillous hypoperfusion in 14 pregnancies complicated by severe placental 
dysfunction at 28 weeks’ gestation. The 14 pregnancies were compared to 12 controls 
at the same gestational age without signs of placental dysfunction. In the dysfunctional 
placentas, they demonstrated a slow MRI signal enhancement and a lower MRI signal 
intensity within the intervillous space after 2 minutes compared to the controls. 
Moreover, in the dysfunctional placentas, they did not observe a MRI signal plateau 
and a culminating negative slope, marking the beginning of contrast washout in the 
controls. They also found that the signal enhancement was rather uniform distributed 
within the controls, whereas the dysfunctional placenta displayed many underperfused 
areas. Finally, it should be noticed that no signal changes were evident in the fetuses, 
indicating that the observed signal changes arose only from the intervillous 
circulation. Thus, they demonstrated that in early-onset dysfunctional placentas, the 
intervillous circulation, and thereby most likely the oxygenation of the intervillous 
space, is severely impaired. In accordance with these MRI findings is a placental 
scintigraphy study by Nylund et al. (119). They demonstrated an impaired 
uteroplacental perfusion in FGR pregnancies using intravenous indium-113m chloride 
injection. The maximum activity (100%, proportional to the blood volume), the rise 
time in counts (the time between 5 and 95% of the maximum activity), and the blood 
flow index (maximum activity/rise time) were significantly reduced in FGR 
pregnancies compared to normal controls.  
Fetal hypoxemia in pregnancies complicated by placental dysfunction may also arise 
from reduced fetal oxygen extraction, as proposed in the third category in the model 
by Kaufman and Kingdom. This suggestion is based on the results of a study by Pardi 
et al. (120). In that study, it was demonstrated that the oxygen contents in the uterine 
vein obtained during cesarean section was higher in FGR cases, which was interpreted 
as a reduced fetal oxygen extraction. However, as commented by Burton GJ (121), 
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oxygen levels were also higher in the maternal arterial blood in those FGR cases. 
Nonetheless, the findings by Pardi et al. may indicate that in some cases of placental 
dysfunction, the reduced oxygen delivery to the fetus may be a result of reduced 
oxygen extraction rather than intervillous hypoxia. Thus, the oxygen transfer in some 
dysfunctional placentas may be diffusion limited due to reduced surface area and 
increased thickness of the villous membrane and/or impaired fetoplacental circulation 
as evidenced by Doppler studies (84,96,122,123). This may also be supported by a 
study using near infrared spectroscopy, in which intervillous space oxygen indexes 
used as proxies of intervillous space oxygen sO2 were higher than normal in small for 
date pregnancies prior to delivery in 37 weeks’ gestation (49). Placental pathological 
examination, however, was not performed in that study, neither were any Doppler 
findings reported.  
In conclusion, controversies exist regarding the placental oxygen environment and the 
placental transfer of oxygen in pregnancies complicated by placental dysfunction. 
Whereas it has been demonstrated that the fetoplacental blood is hypoxemic, the 
oxygenation of the intervillous space and the cause of the fetoplacental hypoxemia 
may vary. This may, to a great extent, reflect heterogeneities in phenotypes of 
placental dysfunction regarding gestational age at disease onset, Doppler findings in 
umbilical and uterine arteries, and placental pathological findings. Nonetheless, in 
theory, the average oxygenation of the entire placenta should be reduced in 
pregnancies complicated by placental dysfunction. 
2.2.4. MANAGEMENT AND OBSTACLES IN CLINICAL PRACTICE 
In modern obstetrics, detecting, diagnosing, and predicting placental dysfunction are 
major challenges due to several factors. The most important factor is that no clinical 
applicable direct measurement of placental function exist, and therefore, the detection 
and diagnosis of placental dysfunction rely on indirect estimates. This has led to a 
wide variety of definitions of placental dysfunction and FGR being used in the 
literature and in clinical practice (124,125).  
The estimated fetal weight (EFW) 
During pregnancy, the most common indirect estimate of placental function is the 
ultrasound EFW, in which a low EFW indicates potential placental dysfunction. 
However, using ultrasound EFW it is not possible to distinguish fetuses that are 
growth restricted due to placental dysfunction and fetuses that are constitutionally 
small. Furthermore, EFW fails in detection of the growth restricted fetuses that are 
not SGA. Low EFW is a known risk factor for stillbirth; however, in approximately 
two thirds of stillbirths occurring at term, the neonate has a normal birth weight (126). 
Thus, focusing merely on the EFW does not identify a large proportion of fetuses at 
risk of stillbirth. Another limitation of the EFW is that the accuracy of the 
measurement is compromised by large intra- and interobserver variability (127) and 
errors in the weight-estimating formulas including the use of two-dimension 
measurements to estimate three-dimension volume, and the use of fetal volume to 
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estimate fetal weight. There is evidence that the least accurate estimates are in the 
very small and very large fetuses (128). Furthermore, one should keep in mind that 
EFW at a single ultrasound scan gives information about fetal size but not about fetal 
growth velocity. In order to assess fetal growth velocity, the use of longitudinal EFW 
measurements are required, in which impaired fetal growth can be defined as 
deceleration in growth between at least two scans two weeks apart. Thus, longitudinal 
scans are required to detect abnormal fetal growth velocity; however, multiple scans 
may be limited by the resources available in many clinical settings. 
Cut-of values and growth curves 
The diagnosis of placental dysfunction based on EFW and/or birth weight is 
complicated by the use of different cut-of values to define FGR. According to the 
American College of Obstetricians and Gynecologist (ACOG), FGR is diagnosed 
when the EFW is below the 10th percentile (4); however, other cut-of values may be 
used including the 3rd, 5th or 15th percentile for gestational age or 2 standard deviations 
below the mean for gestational age. Furthermore, the use of various growth curves in 
different countries is a matter of debate. Some use growth reference curves 
representative of an entire population. These reference curves describe how fetuses 
(and neonates and infants) have grown at a particular time and/or place. The reference 
curves may be based on either ultrasound EFW or birth weights. In the latter case, 
however, as preterm infants are more likely to be growth-restricted (129,130), 
population reference curves based on birth weight tend to underestimate SGA in 
preterm births. Others use population standard curves usually only based on low-risk 
pregnancies with normal outcomes. Thus, a standard curve describe how fetuses (and 
neonates and infants) should grow when constrains on growth are minimal. Another 
approach is the use of customized curves, rather than population charts. Using a 
customized curve, the birth weight is adjusted for maternal characteristics (maternal 
height, weight, parity, ethnicity etc.). It has been suggested that using a customized 
curve, the fetuses identified as SGA are at higher risk of adverse outcomes than SGA 
fetuses identified using population charts (131). However, controversies exist 
regarding customization, as some of the adjusted factors themselves are risk factors 
(132,133). 
In Denmark, an EFW < -15% based on the intrauterine growth curve by Marsal et al 
(134) is considered at risk of FGR during pregnancy, whereas low birth weight is 
defined by a birth weight < -22% using the same reference. The growth curve by 
Marsal et al. is based on a longitudinal study of 86 uncomplicated pregnancies (759 
EFWs) with normal neonatal outcomes from four Scandinavian centers. Using this 
growth curve, the incidence of low birth weight (< -22%) in Denmark has been 
estimated to be 2.8% (135). 
Ultrasound Doppler assessments 
During pregnancy, ultrasound Doppler measurements of fetal and maternal vessels 
are often included in order to risk stratify the pregnancy and to detect placental 
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dysfunction. Moreover, fetal Doppler measurements are also used to examine fetal 
well-being and compensatory adaptations to hypoxia (136). Doppler flow velocities 
of the arteries on both sides of the placenta provide indirect measurements of 
uteroplacental and fetoplacental circulations and thereby placental function. As 
absolute blood flow volume measurements are dependent on the insonation angle and 
diameter of the vessels, the Doppler flow velocity waveform is usually analyzed and 
characterized by other indices. Often, the waveform is characterized by the pulsatility 
index (PI), which is a measurement of the blood flow resistance in a vessel ((peak 
systolic velocity – minimum diastolic velocity)/mean velocity during cardiac cycle)). 
As opposed to absolute blood flow volume measurements, the PI is an angel 
independent measurement in which the vessel diameter need not to be known. 
However, the interpretation of the PI is complex, as it does not directly reflect flow. 
In arteries, the diastolic flow velocity represents downstream resistance, although 
other parameters such as fetal heart rate and blood flow viscosity may also affect the 
flow velocity waveform. These parameters, however, should not be of clinical 
significance. Moreover, maternal position and fetal breathing movements may affect 
the velocities. Therefore, the assessment should be performed with the mother in a 
slightly tilted lateral position in order to avoid vena cava compression and subsequent 
uteroplacental hypoperfusion. Furthermore, the assessment should not performed 
during fetal breathing movements. The most frequently used Doppler flow velocity 
measurements are shortly presented in the following.  
Uterine artery (UtA) Doppler. In pregnancies complicated by placental dysfunction, 
the UtA flow may be compromised due to impaired transformation of the spiral 
arteries into low resistance vessels (29,96). Therefore, the assessment of UtA Doppler 
flow velocities may be used to distinguish the FGR fetus from the small for date fetus 
(137,138) or even predict FGR during early pregnancy (139). However, not all 
pregnancies complicated by placental dysfunction have an elevated UtA PI (106) and 
the measurement is limited by rather large intra- and interobserver variabilities (140). 
Hence, the performance of UtA PI varies in the prediction of low birth weight and as 
a freestanding test, the measurement is inaccurate (141-146). Even in the third 
trimester, the UtA PI detection rate of low birth weight (< 5th percentile) for those 
delivering < 5 weeks following assessment is only 44% at a false positive rate of 10% 
(143).   
 
Umbilical artery (UA) Doppler. An elevated UA PI reflects increased fetoplacental 
resistance as it is associated with maldevelopment of the placental terminal villous 
tree and stem villus vasoconstriction (94,99,104)). FGR pregnancies with preserved 
end-diastolic UA flow may be associated to a normal or a proliferative villous 
response (accelerated villous maturation) (3,96,104,147), whereas placentas from 
pregnancies with an absent or reversed UA flow may be associated to villous 
hypoplasia (3,94,104). Raised UA PI is an early sign of placental dysfunction, which 
typically precedes abnormalities in other parameters used in the assessment of fetal 
well-being, including Doppler findings in the MCA and DV as described below, 
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changes in biophysical profile and changes in fetal heart rate patterns (148,149). An 
elevated UA PI may progress towards an absent or even reverse end-diastolic flow 
velocity and it has been demonstrated that absence of end-diastolic flow velocity is 
correlated to fetal acidemia (150,151). However, the progression of an elevated UA 
PI varies (136), and some FGR fetuses have normal UA PI, particular the late gestation 
FGR fetuses (88).  
 
Middle cerebral artery (MCA) Doppler and the cerebroplacental ratio (CPR). 
Other Doppler flow parameters to be used in the fetal and placental assessment include 
the PI of the fetal MCA and the CPR, which is the ratio between the UA PI and the 
MCA PI (152). Brain sparing refers to fetal cerebral vasodilation in response to 
perceived hypoxemia, which is followed by a decrease in the MCA PI.  It is one of 
the fetal adaptive responses to reduced available oxygen and nutrition, in which the 
blood is redistributed towards the vital organs including the fetal brain, myocardium 
and the adrenals (153). In early-onset placental dysfunction, a low MCA PI is typically 
observed in fetuses with reduced umbilical flow, whereas in late gestations, up to 20% 
of SGA fetuses with normal UA PI have a low MCA PI (154), which is also associated 
to adverse neonatal outcomes (155). In case of fetal metabolic acidosis, the ability to 
maintain the centralization of the fetal blood flow may be lost (156). Thus, 
normalization of a reduced MCA PI in severely compromised fetuses may occur. A 
low CPR reflects cardiac redistribution in favor of the brain, which may be observed 
in milder placental dysfunction (153) with only slight abnormalities in the UA and 
MCA PI. In early-onset disease, a low CPR may precede abnormal UA PI and MCA 
PI. On the contrary, in late-onset disease, a low CPR may be the only Doppler sign of 
fetal adaptive response to reduced oxygen supply (7). In these pregnancies, the fetus 
may undergo rapid deterioration without any further Doppler signs. Studies have 
demonstrated that a low CPR is an independent predictor of adverse neonatal outcome 
regardless of fetal size (157,158).Therefore, in the third trimester, the CPR may be an 
important tool in the assessment of fetal well-being and it may be able to detect those 
FGR fetuses that are not SGA. 
 
Ductus venosus (DV) Doppler. Alterations of DV flow velocity waveforms are in a 
closer temporal relationship to intrauterine fetal demise, compared to changes in 
arterial flows as described above (136,159). Therefore, in severe growth-restricted 
pregnancies, DV flow velocities in combination with fetal heart rate patterns are used 
to assess fetal well-being and timing of preterm delivery (160,161). The DV shunts a 
proportion of the well-oxygenated blood from the umbilical vein towards the fetal 
heart and brain, thereby bypassing the fetal liver. The degree of shunting depends on 
the fetal oxygen supply as the DV shunting is increased during hypoxia (162). 
Increased DV PI and reduced blood flow velocity, which may even be reversed during 
atrial contractions in case of severe hemodynamic compromise, reflect an increased 
right ventricular afterload and eventually myocardial dysfunction (159,163,164) and 
the DV indices are associated to fetal acidemia (163). 
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Postpartum diagnosis  
Postpartum diagnosis of placental dysfunction also represents a major challenge. The 
postpartum diagnosis is often based on the birth weight percentile; however, as is the 
case of the prenatal EFW, birth weight percentile does not distinguish between small 
for date neonates and FGR neonates; neither does it include those FGR neonates that 
are not born small for date. The postpartum diagnosis may be confirmed by placental 
pathological examinations, in which various pathological signs indicate placental 
dysfunction (85) as described in Chapter 2.2.1. Nonetheless, in some dysfunctional 
placentas, no such signs exist, and in placentas from clinical uneventful pregnancies, 
these signs may be present (90). Furthermore, placental pathological examination is 
not performed routinely in all pregnancies. Therefore, neither birth weight percentile, 
nor placental pathological examination may be a perfect proxy of placental 
dysfunction. Other proxies of placental dysfunction may include adverse outcome 
measurements including stillbirth, delivery before 32-34 week’s gestation etc. or the 
assessment of catch-up growth in early postnatal life, which may indicate an impaired 
intrauterine placental environment.  
Prediction of FGR and adverse outcomes 
In clinical practice, prediction of FGR and adverse outcomes due to placental 
dysfunction is of great importance in the risk stratification of the pregnant women, 
preferable in early gestation.  Several predictive models at various gestations have 
been proposed. These models may include EFW, Doppler measurements, maternal 
characteristics and maternal blood pressure, and/or biochemical markers such as 
placental growth factor (PlGF), soluble Fms-like tyrosin kinase-1 (sFtl-1), pregnancy-
associated placental hormone (papp-A) etc. The parameters have been assessed as 
freestanding tests and in various combinations, but the predictive values are varying 
(165-171). Moreover, comparison of the different models is difficult due to 
heterogeneities in study populations, definitions of FGR and outcome measurements. 
Furthermore, many of the models include a third trimester scan, which is not part of 
routine practice in many countries.  
Conclusion 
In clinical practice, detecting, diagnosing, and predicting placental dysfunction and 
the associated adverse outcomes are major challenges due to several factors as 
discussed above. A direct, reliable measurement of placental function in vivo may 
overcome these challenges. Therefore, the key to more effective clinical management 
may be to identify direct placental biomarkers of placental dysfunction rather than 
indirect estimates of this condition. One potential biomarker is placental hypoxia, 
which may be detected using MRI.  
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2.3. MAGNETIC RESONANCE IMAGING 
MRI was invented in 1972 by the American chemist, Poul C. Lauterburg, while the 
basic physic fundamentals for MRI were discovered even decades before. Ever since, 
MRI has undergone a dramatic development and nowadays, MRI has a broad range 
of applications and it is widely used in the diagnosis of medical disease. In 2003, Poul 
C. Lauterburg and Sir Peter Mansfield were awarded the Nobel Prize in Physiology 
or Medicine for their discoveries concerning MRI. Their work has led to the 
development of modern MRI, which represents a breakthrough in medical diagnostics 
and research. 
2.3.1. BASIC MRI PRINCIPLES 
MRI is based on the magnetic properties of certain atom nuclei. The most important 
nuclei is the hydrogen nucleus, being present in water and thus in all tissue. This 
nucleus has an electrical charge and possesses a spin, creating its own intrinsic 
magnetic field. Therefore, each nucleus acts like a small magnet and, when placed in 
an external magnetic field, partially aligns with the external magnetic field. Most 
nuclei align parallel with the external field (low-energy state), while others align anti-
parallel to the external field (high-energy state). In addition to the spin around the 
nucleus axis, the external magnetic field induces another spin around the axis in the 
external magnetic field. This spin is also called precession (Figure 1) (172).  
 
Figure 3. Illustration of the nucleus spin and precession 
The precession frequency can be described by the Larmor equation: 
ώ = γ Β0 (1) 
in which ώ is the precession frequency given in Hz (or MHz), γ is the gyromagnetic 
ratio and Β0 is the external magnetic field strength, given in Tesla (T). The sum of the 
alignment of the nuclei creates a magnetic vector in the direction of Β0, creating the 
Z-axis or the longitudinal magnetization. Applying a radiofrequency (RF) excitation 
pulse, causes disturbance of the orientation of the nuclei, as some nuclei changes 
orientation in the opposite direction in the Z-plane (high-energy state), thereby 
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reducing the longitudinal magnetization. Furthermore, the nuclei starts to precess in 
phase, thereby creating a magnetic vector that precesses with the precession frequency 
in the X-Y-plane and a transversal magnetization is created. Thus, the magnetic vector 
has been “flipped” 90° (Figure 4). 
 
Figure 4. To the left: nuclei alignment and phase coherence during equilibrium (top) and 
excitation (bottom). To the right: direction of the magnetic vector (M). 
When the RF excitation pulse has stopped, the nuclei returns to the low-energy 
equilibrium state by two independent relaxation processes known as T1 and T2 
relaxation (Figure 5): 
T1 relaxation: The nuclei return towards the longitudinal equilibrium state, in which 
the obtained energy from the excitation pulse exchanged with the surroundings – or 
the lattice, thereby rebuilding the longitudinal magnetization. This exponential 
process is also known as the spin-lattice relaxation or longitudinal relaxation. The 
speed of this process is described by the tissue longitudinal relaxation time constant, 
T1, given in milliseconds (ms). The T1 relaxation time is defined as the time when 
63% of the longitudinal magnetization has recovered.  
T2 relaxation: Meanwhile, as the T1 relaxation occur, the nuclei get out of phase, 
thereby reducing the transversal magnetization, an exponential process also known as 
spin-spin relaxation as it depends the presence of random local magnetic fields 
created by neighboring nuclei. The speed of transverse magnetization decay is 
described by the transversal relaxation time constant, T2, given in ms, which is 
defined as the time when the transverse magnetization is reduced to 37%. 
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Figure 5. Left: T1 relaxation. Right: T2 relaxation 
In addition to the spin-spin relaxation, the transverse magnetization decay depends on 
local magnetic inhomogeneities within the external magnetic field causing the nuclei 
to get out of phase faster and thereby, shortens the decay of the transverse 
magnetization. The combined effect of T2 relaxation and relaxation due to magnetic 
field inhomogeneities is called the T2* relaxation (Figure 6). Thus, the T2* 
relaxation is shorter than the T2 relaxation (30). The relation between T2* relaxation 
and T2 relaxation can be described by the following equation: 
1 / T2* = 1 / T2 + 1 /T2´ (1) 
In which T2’ is the relaxation caused by magnetic field inhomogeneities. 
 
 
Figure 6. T2* relaxation (dashed line) 
The longitudinal and transverse relaxations are independent processes; however, they 
occur parallel thereby leaving a sum magnetizing vector (the sum of the longitudinal 
and transversal magnetization) to perform a spiraling motion during relaxation in 
which the obtained energy is released (Figure 7).  
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Figure 7. Left: the spiraling motion of the magnetic vector (M) during relaxation. Right: the 
corresponding free induction decay curve. 
During relaxation, the energy is released as RF pulses, also known as the free 
induction decay (FID), which represent the exponentially T2* decade of the 
magnetization. These signals cannot directly be transformed into MR images, as there 
is no spatial information in FID signals. For this purpose, the exact signal position in 
the X, Y, Z-plane has to be determine using frequency -, phase - and slice encoding 
gradients, respectively. Then using Fourier transformation, the signals can be assigned 
to a certain location, and the MR image can be constructed. In order to enhance the 
signal, a refocusing gradient (gradient-echo (GRE) MRI) or a 180° refocusing RF 
pulse (spin-echo (SE) MRI) can be applied, which refocuses the magnetization 
creating an echo of the signal, which is measured later. 
MRI sequence and sequence parameters: The relaxation times are tissue specific 
constants that varies between tissues and pathology and as such, they are the primary 
source of tissue contrast in a MR image. The dominant source of tissue contrast in an 
MR image depends on the choice of MRI sequence and sequence parameters. An MRI 
sequence has a specific number, strength and timing of RF excitation pulses and 
gradients and the three main sequence parameters are: 
 Repetition time (TR): TR is the time between two consecutive RF excitation 
pulses. A short TR increases the T1-weightning in the MR image. 
 
 Echo time (TE): TE is the time between an RF excitation pulse and the echo. 
A long TE increases the T2/T2*-weighting in the MR image. In multiple 
echo sequences, several TE may be used between consecutive RF excitation 
pulses.  
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 Flip angle: The RF pulse flips the magnetic vector into the transversal plane, 
thereby reducing the longitudinal magnetization and increasing the 
transverse magnetization. The flip angle is the amount of rotation of the 
magnetic vector into the transversal plane and it can vary between 0 and 
180° in MRI sequences depending on the magnitude and duration of the RF 
excitation pulse. A RF excitation pulse that tips the magnetic vector 90°, as 
illustrated in Figure 4, is called a 90° pulse. Reducing the flip angle produces 
less T1-weighting in the image. 
2.3.2. T2*-WEIGHTED IMAGING 
In T2*-weighted MRI, differences in T2* relaxation are the primary source of tissue 
contrast. As deoxyhemoglobin is a paramagnetic molecule, it induces local constant 
magnetic field inhomogeneities, which shortens the T2* decay. Therefore, T2*-
weighted imaging is sensitive to tissue sO2. This effect is also known as the Blood 
oxygen level dependent (BOLD) effect, which was discovered in 1990 by Ogawa et 
al. (173). In 1936, Pauling et al. (174), described the basic magnetic properties of 
deoxyhemoglobin and oxyhemoglobin. They revealed that the paramagnetic effects 
of deoxyhemoglobin are caused by the unpaired electrons of the heme groups. The 
unpaired electrons produce spin, and thereby pronounced magnetic susceptibility, 
which induces magnetic field inhomogeneities in a magnetic field. Oxyhemoglobin 
does not contain unpaired electrons, and therefore it does not induce these magnetic 
field inhomogeneities. Thus, during hyperoxia, the amount of deoxyhemoglobin and 
thereby the presence of local inhomogeneities, is reduced, which prolongs the T2* 
decay. On the contrary, during tissue hypoxia, the amount of deoxyhemoglobin is 
increased, which reduces the T2* decay. Due to these different magnetic properties, 
deoxyhemoglobin can be regarded as an intrinsic contrast agent.  
The BOLD effect can be measured using T2*-weighted imaging and the effect is most 
pronounced on gradient recalled echo (GRE) sequences. Using these sequences, the 
imaging can be carried out by measuring signal intensities or by measuring the T2* 
relaxation time. In this thesis, the BOLD method refers to the dynamic assessment of 
changes in signal intensities, whereas the T2* method refers to measurement of 
absolute T2* values. In the following, a GRE sequence is described, and how the 
sequence is used in the BOLD method and in the T2* method.  
Gradient recalled echo (GRE) MRI sequence 
A GRE sequence is illustrated in Figure 8. In a GRE sequence, the MRI signal is 
refocused using magnetic field gradients, in which an uneven magnetic field (a 
gradient field) is superimposed on the existing magnetic field. When the gradient is 
turned on, the gradient field increases the amount of magnetic field inhomogeneities 
and the protons dephase, thus the transversal magnetization disappears. Then the 
gradient is switch off and on again in the opposite direction, thereby rephrasing the 
protons to some extent and the signal is enhanced. This enhanced signal is called a 
gradient recalled echo. The magnitude of this echo depends on the tissue T2* decay 
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as the reversal gradient fields do not neutralize the local magnetic inhomogeneities. 
Therefore, GRE sequences are sensitive to the presence of paramagnetic substances 
including deoxyhemoglobin. The extent of T2*-weighting in GRE MRI depends on 
the sequence parameters. Reducing the flip-angel and increasing the TR produces less 
T1 weighting, whereas longer TE produces more T2*-weighting.   
 
Figure 8. A GRE MRI sequence. Details are described in the text above. 
Single-echo GRE – The BOLD method 
The BOLD method is carried out using a single-echo GRE sequence as described 
above. The magnitude of the echo signal can be simply described by the following 
equation: 
S  M0 e(-TE/T2*)  (2) 
In which S is the absolute BOLD signal, M0 is the relaxed magnetization (or the 
equilibrium vector, Figure 4), TE is the echo time and T2* is the transversal relaxation 
time. The relaxed magnetization depends on multiple factors including 1) technical 
factors such as the magnetic field strength, sequence parameters, distance to the 
receiver coil, the shimming effects etc. and 2) baseline physiological factors such as 
tissue blood flow, blood volume, hydration, temperature, hematocrit, oxygenation and 
tissue compositions etc. (175,176). As these factors may vary between individuals, 
the absolute signal (S) cannot be directly inferred into tissue sO2, neither can it be 
compared between individuals. Dynamic changes in the signal, however, as can be 
induced by varying the tissue sO2 and thereby the T2* value in equation (2), are 
comparable between individuals. Thus, instead of comparing absolute BOLD signals, 
relative BOLD signal changes, given as a percentage of the baseline BOLD signal, 
are compared between individual.    
 
Multi-echo GRE – The T2* method 
The T2* value in equation (2) can be measured using a multi-echo GRE sequence. 
This sequence can be obtained within short breath-holds by reducing the flip-angels 
and the TR. In multi-echo GRE, additional opposing gradients are applied creating 
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multiple echo signals at varying echo-times. A multi-echo sequence with three TE’s 
is illustrated in Figure 9.  
 
Figure 9. A Multi-echo GRE sequence. In this figure, three TE’s are illustrated. Details are 
described in the text. 
Using this multi-echo GRE sequence, the T2* value of a tissue can be estimated as 
follows; for each TE the mean MRI signal of a ROI is plotted, and the mono-
exponential decay function (equation (2)) is created as illustrated in Figure 10. 
 
Figure 10. The mono-exponential decay function achieved using the multiple-echo MRI 
sequence (five TE’s are illustrated). 
Using the multiple values of signal S at the varying TE, the equation (2) can be solved 
for T2* using a non-linear least squares fitting algorithm (177). Thereby, the tissue 
specific T2* value can be achieved. As this T2* value is calculated based on multiple 
signals at varying TE’s with M0 being a free parameter, it does not depend on the M0 
and therefore it can be compared between individuals. Thus, as opposed to the 
absolute BOLD signal, absolute T2* values can be compared between individuals. 
However, like the BOLD signal, the T2* value cannot directly be inferred into tissue 
sO2 as the T2* value also depends on elements of tissue composition such as cell 
density, water content, surface areas etc. (the intrinsic T2 value, equation (1)) (178).  
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Oxygen-challenge during placental T2*-weighted MRI 
As described above, changes in tissue sO2 during oxygen-challenge can be depicted 
using T2*-weighted imaging. This has been demonstrated in several MRI studies with 
direct measurements of changes in oxygen contents during hyperoxia/hypoxia (179-
184).  Oxygen-challenge can be performed using a none-rebreather facial mask, in 
which exhaled gases are not rebreathed.  During oxygen-challenge, the oxygen 
content of the blood rises. As arterial blood is nearly fully saturated during normoxia, 
oxygen-challenge increases the arterial pO2 whereas it has little impact on arterial sO2 
according to the oxygen hemoglobin dissociation curve (185,186). Thus, the T2*-
weighted MRI signal of arterial blood is sparsely affected during oxygen-challenge. 
On the contrary, in venous low-saturated blood, the additional oxygen binds to 
deoxyhemoglobin, thereby increasing the venous sO2 whereas the change in venous 
pO2 is relatively small. Thus, during oxygen-challenge, the T2*-weighted MRI signal 
within venous, low-saturated blood is increased.  
Within the placenta, changes in T2*-weighted MRI signal during maternal oxygen-
challenge may arise from increased sO2 within the low-saturated maternal venous 
blood in the periphery of the intervillous space as well as from increased sO2 of the 
low-saturated fetoplacental blood. The increased sO2 of the fetoplacental blood can 
be explained by the increasing pO2 gradient across the placental membrane during 
oxygen-challenge driving the simple diffusion of oxygen towards the fetoplacental 
blood, thereby increasing the sO2 (187,188). Different methods have demonstrated 
increased fetoplacental oxygen content during maternal oxygen-challenge. These 
methods include for instance invasive studies of the rhesus monkey (188) and the 
sheep (179,189), blood gas analysis of the human umbilical cord blood obtained by 
cordocentesis in growth-restricted pregnancies (190) and human MRI methods 
(191,192). Although, changes in placental T2*-weighted MRI signal during maternal 
oxygen-challenge may arise from increased placental sO2, one should keep in mind 
that changes in other parameters during oxygen-challenge may affect the T2* value, 
and thereby the MRI signal. Such factors may include changes in placental blood flow 
and blood volume, both of which affect the amount of deoxyhemoglobin within a 
voxel (183). Therefore, using the BOLD method or the T2* method, MRI changes 
during oxygen-challenge cannot be directly inferred into quantitative changes in sO2. 
Moreover, using the dynamic BOLD method, in which signal changes are measured 
in relative values, baseline conditions affecting the baseline signal, such as baseline 
oxygenation, blood flow, blood volume, tissue morphology etc., may modulate the 
BOLD response amplitude (176,193,194). These factors needs to be considered when 
interpreting changes in placental T2*-weighted signals during oxygen-challenge.    
Previous studies on placental T2*-weighted imaging 
Placental T2*-weighted imaging has been performed in animal studies (58,181,195-
198) and in a few human studies (59,199) in order to investigate the placental oxygen 
environment. Moreover, the T2*-weighted methods have been used in several animal 
and human fetal studies (179-181,191,192,196,197,200-207). In normal human 
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pregnancies, Huen et al. (199) demonstrated a significant increase in placental T2* 
value during maternal oxygen-challenge, whereas neither this increase nor the 
normoxic T2* value was found to be correlated with gestational age. Using the 
dynamic BOLD sequence, Sorensen et al (59) demonstrated a significantly increase 
in placental BOLD response during oxygen-challenge. The authors suggested that the 
increased BOLD response represented increased fetoplacental sO2. Prior to this thesis, 
no T2*-weighted placental studies were published in human pregnancies complicated 
by placental dysfunction. However, in rat FGR models induced by ligation of one 
uterine artery, it has been demonstrated that the BOLD response during oxygen-
challenge is significantly reduced (196,197).  
MRI B0 inhomogeneity and susceptibility artefacts in T2*-weighted imaging 
Several types of MRI artefacts exist and they may interfere with the MRI results. 
Using T2*-weighted imaging, B0 inhomogeneity and magnetic susceptibility artefacts 
need to be considered. An exceptionally homogenous static magnetic field is required 
for MRI, especially at the core of the scanner. Placing a patient within the MRI 
scanner reduces the overall homogeneity of the magnetic field, especially 
peripherally. The reduced homogeneity can partly be compensated by shimming of 
the magnetic field (208). Moreover, local magnetic inhomogeneities near interfaces 
of tissues may exist due to different magnetic susceptibility within the tissues, i.e. due 
to differences in the extent to which the tissue becomes magnetized when placed 
within a magnetic field. Thus, local inhomogeneities may occur near the interface of 
bone-soft tissues and tissue-air interfaces or by the present of metallic implants etc. 
Such local inhomogeneities shortens the dephasing of spins and thereby reduce the 
signal and the T2* value (209). The artefacts may be detected as image distortions or 
localized signal drop-outs due to this T2* shortening. Susceptibility artifacts increase 
with the main magnetic field strength; thus, they are more pronounced at 3T compared 
to 1.5T (210). GRE sequences are especially prone to the susceptibility artefacts, as 
they do not have a 180° refocusing pulse to compensate for magnetic field 
inhomogeneities. Moreover, the use of long echo times increases the risk of these 
artefacts. Different techniques can be used to reduce susceptibility artefact. The use 
of 1.5T rather than 3T scan system, shorter TE and optimization of the shimming of 
the magnetic field reduce the presence of these artefacts. In addition, it is also 
recommended to use a central position of the ROI in the xy- and z-plane. 
 
2.4. ETHICAL CONSIDERATIONS  
2.4.1. SAFETY IN MRI 
Identifying potentially hazardous effects of MRI during pregnancy is an ongoing 
subject of investigation. The main areas of concern are related to the static magnetic 
field (B0) and the time-varying magnetic field gradients during the MRI acquisitions 
used for spatially encoding of the MRI signals and the RF pulses used for the 
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excitation of protons. To date, no human studies have shown any association between 
MRI and adverse fetal outcome (211-215). 
The static magnetic field  
Potential hazardous effects associated with the exposure of patients to strong static 
magnetic fields have been investigated in several studies and they have been reviewed 
comprehensively, among others, by the International Commission on Non-Ionizing 
Radiation Protection (ICNIRP) (216-218). The static magnetic fields may interact 
with biological tissues and organisms through various physical mechanisms (219). 
One important mechanism is magnetic induction, which may originate from the 
interaction with moving electrolytes in blood vessels, thereby creating electric 
currents. These currents may induce voltages across the membranes, which potentially 
may reduce blood flow velocity and affect the heart rate and rhythm (220,221). 
Studies using cardiotocography during MRI at 1.5T have showed no effects on the 
fetal heart rate (222,223). Another important mechanism is a magneto-mechanical 
effect, which induces reorientation of paramagnetic and diamagnetic molecules in 
order to align their magnetic orientation with the magnetic field. However, as human 
tissue does not contain strong ferromagnetic components and has extremely small 
values of magnetic susceptibility, magneto-mechanical forces are considered too 
small to affect human tissue in vivo. According to a review by the ICNIRP, no 
consistent effects of static magnetic field exposure on reproduction and development 
have been seen in mammalian species (218). However, animal studies have been 
conflicting, as some concerns have been raised regarding fetal growth restriction in 
mice studies. This adverse effect has never been demonstrated in human pregnancy 
(224). 
Time-varying magnetic fields 
Like the static magnetic field, the magnetic gradient fields used for spatial encoding 
of the MRI signal also induce electrical fields and currents with frequencies below 
100 kHz. In this frequency range, the currents may induce voltages across the 
membranes, which potentially may stimulate nerve cells. The primary concern is the 
potential effect on the heart rate and rhythm. However, as mentioned above, no studies 
have demonstrated any effects on the fetal heart rate. 
The rapid alternations of the magnetic gradient fields during the MRI acquisition 
produces noises in the range from 80 to 120 dB (225). Therefore, it is recommended 
to offer hearing protection to the patient. Most likely, the fetus is protected by the 
maternal abdomen and by the amniotic fluid, which reduces fetal noise exposition 
with at least 30 dB (226). Follow-up studies of infants exposed to MRI prenatally have 
demonstrated no adverse effects on hearing (213-215).  
Radiofrequency fields 
The RF pulses used for the excitation the protons typically have frequencies above 10 
MHz, and therefore they do not induce voltage across cell membranes. Rather instead, 
they deposit heat within tissues. During MRI acquisition, a SAR value (Watt/kg) will 
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estimate the amount of thermal energy conducted to the tissues. According to the 
recommendations by the ICNIRP the whole body SAR value should be kept below 2 
W/kg during a one hour scan, equivalent to a rise in adult tissue temperature of 0.5°C 
and a rise of fetal temperature to less than 38°C (227). Numerical simulations of SAR 
and temperature changes in a pregnant human model at 1.5T and 3T MRI scanners 
have been performed (212). The results suggest that for MRI procedures carried out 
under normal mode conditions such that the maternal whole-body SAR is ≤2 W/kg, 
fetal whole-body SAR is 1.24 and 1.14 W/kg at 64 and 128 MHz, respectively. 
Furthermore, the average temperature of the fetus remains below 38°C. Thus, these 
results are in line with the recommendations by ICNIRP. Moreover, changes in fetal 
temperature have been investigated using fiberoptic probes in pregnant pigs during a 
Fourier single-shot turbo spin-echo (HASTE) sequence (228). This sequence has the 
potential to generate more heat than traditional sequences; however, no significant 
changes in temperature were measured in the fetal brain, abdomen or amniotic fluid.  
In summary, no evidence of adverse fetal effects to MRI at low field strength has been 
demonstrated. Nonetheless, proper precautions as stated by the ICNIRP (227) must 
be taken, in particular in the first trimester in which the rapidly dividing cells are 
thought to be particular vulnerable.  
 
2.4.2. OXYGEN-CHALLENGE 
In most obstetric units maternal oxygen supply is standard treatment in case of fetal 
bradycardia during labor (229,230) and supplementary maternal oxygen is a standard 
procedure before elective and emergency caesarian section (231,232). One area of 
concern in relation to these procedures has been the potential vasoconstrictive effect 
of oxygen. Several Doppler ultrasound studies have shown that short-term oxygen 
supply has no effect in uncompromised fetuses (233-235). Likewise, using MRI, it 
has been demonstrated that short-term maternal oxygen supply does not alter fetal 
brain oxygenation in uncompromised fetuses (191,236). In compromised fetuses, 
maternal oxygen supply can normalize fetal movements and brain sparring, whereas 
in severely compromised fetuses, oxygen supply may have no effects on fetal 
movements or Doppler flows (235,237). Studies on the fetal heart rate in growth-
restricted fetuses during maternal oxygen supply has shown an increasing number of 
accelerations and increasing variability (238,239). Bekedam et al. found a significant 
increase in number of fetal heart rate deceleration in growth-restricted fetuses after 
discontinuation of the maternal oxygen supply (239), observations that could not be 
confirmed by Kyank et al. and Bartnicki et al.(238,240).  
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CHAPTER 3. AIM OF THE THESIS 
The overall purpose of this project was to investigate the feasibility of T2*-weighted 
MRI as a non-invasive method for detection of placental hypoxia and thereby 
placental dysfunction. 
The specific aims of the studies in the project were: 
Placental T2* measurements: 
 To evaluate the reproducibility of placental T2* measurements (Study I). 
 
 To investigate the T2* value in normal pregnancy and in those complicated 
by placental dysfunction (Study I). 
 
 To investigate and compare the performance of placental T2* and the UtA 
PI in the prediction of low birth weight (Study IV). 
Placental BOLD MRI 
 To investigate the relative ∆BOLD response during oxygen-challenge in 
normal pregnancy and in those complicated by placental dysfunction (Study 
II and V). 
 
 To evaluate the presence of spontaneous uterine contractions during BOLD 
MRI and their placental physiological effects (Study III). 
 
 To interpret the relative ∆BOLD response using placental T2* estimates of 
placental baseline conditions, including baseline oxygenation and tissue 
morphology, in normal pregnancies and in those complicated by placental 
dysfunction (Study V). 
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CHAPTER 4. MATERIAL AND 
METHODS 
4.1. GENERAL STUDY POPULATION 
Study I-V are based on an original cohort of 128 singleton pregnancies recruited at 
the Aalborg University Hospital during 2011 and 2016 (Figure 11). We included 
women > 18 years of age, carrying singleton pregnancies with no fetal malformation 
or abnormal karyotype. Women with preexisting diabetes or gestational diabetes, BMI 
> 34 (for technical reasons), severe claustrophobia or contradictions to MRI were not 
included. Oral and written informed consents were obtained from all participating 
women. The project was approved by the Regional Committees on Biomedical 
Research Ethics (Journal number M-20090006 and N-20090052) and reported to the 
Danish Data Protection Agency (2008-58-0028).  
 
Figure 11. Flow chart of the MRI study population. 
A subset of the 128 women underwent repeated MRI examination in order to 
investigate the reproducibility of the T2* method (study I), and another subset of the 
128 women underwent repeated MRI examination within weeks in order to obtain 
longitudinal MRI data (not reported in this thesis).  
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4.2. STUDY DESIGNS AND POPULATIONS IN STUDY I-V  
Study I  
This T2* study was a cross-sectional study, in which placental T2* was investigated 
in 24 uncomplicated pregnancies at 24 - 40 weeks’ gestation. Furthermore, we 
included four cases with EFW Z-scores < -3.5 (134) at the time of MRI (24-31 weeks’ 
gestation). Case 1 had normal ultrasound Doppler findings, whereas case 2, 3 and 4 
had abnormal Doppler PI in the UA (Z-score > 2.0 (241)) and in the MCA (Z-score < 
-2.0 (241)) and in case 4, even the DV PI was increased (Z-score > 2.0 (242)). Doppler 
findings were normal in the uncomplicated pregnancies. Placental T2* analysis was 
performed prospectively at the time of MRI, thus the neonatal outcomes were not 
known at the time of the T2* analysis. The reproducibility of the T2* methods was 
also investigated. In the group of uncomplicated pregnancies, a subset of the women 
(n = 16) underwent repeat T2* scan after 2 minutes while the women remained on the 
board in the same position. In a subset of these 16 women (n = 8), the placental T2* 
was repeated in a separate session after a 45-minute interval in which the women left 
the MRI suite. In this study, normal birth weight was defined by a Z-score > -2.0 
(134). Placental pathological examination was performed in the four cases. 
Study II 
This BOLD study was also a cross-sectional study, in which placental BOLD MRI 
was investigated in 21 uncomplicated pregnancies at 24 - 40 weeks’ gestation (33 ± 
5, mean ± SD). Moreover, we included four cases with EFW Z-score < -3.5 at the time 
of MRI (24-31 weeks’ gestation). These pregnancies also participated in Study I. 
Unfortunately, the case numbering was changed. Thus, in this study, case 1, 2 and 3 
had abnormal UA and MCA Doppler findings at the time of MRI. In case 1, the DV 
PI was also increased, whereas this figure was normal in case 2 and 3. Case 4 and the 
21 uncomplicated pregnancies had normal Doppler findings. Placental BOLD MRI 
analysis was performed by one single observer, who was not blinded to the neonatal 
outcomes. Normal birth weight was defined by a Z-score > -2.0. Placental 
pathological examination was performed in the four cases.    
Study III 
In this BOLD study, we aimed to investigate the presence of spontaneous uterine 
contractions during BOLD MRI scans. It was a cross-sectional study, in which we 
analyzed the 5-minute normoxic placental BOLD MRI of 56 uncomplicated 
pregnancies with normal neonatal outcomes including normal birth weight defined by 
a Z–score > -2.0. At the time of MRI (23 - 40 weeks’ gestation), ultrasound EFW and 
Doppler findings were normal. 
Study IV 
In this T2* study, we investigated the relation between placental T2*, UtA PI and 
birth weight, and we compared the performance of T2* and UtA PI in the prediction 
of low birth weight defined by a Z-score ≤ - 2.0. Secondary outcome was abnormal 
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placental pathological findings. It was a prospectively observational study, in which 
100 pregnancies attending for routine or specialist examination were included at 20 - 
40 week’s gestation. The study population was mixed regarding the risk of low birth 
weight based on the ultrasound EFW. At the time of inclusion, 68 out the 100 
pregnancies had an EFW > -15%, whereas 32 had an EFW ≤ - 15%. Out of these 32 
pregnancies, five had an elevated UA PI. At the day of MRI (20-40 week’s gestation), 
an additional ultrasound examination was performed, including measurement of the 
UtA PI. 
Study V 
In this study, we aimed to interpret the relative ∆BOLD response by using placental 
T2* estimates of placental baseline conditions in normal pregnancies and in those 
complicated by placental dysfunction. Originally, we included 68 normal, uneventful 
pregnancies with normal neonatal outcome including normal birth weight at term 
defined by a Z-score > -1.28 (> - 15%), and 23 cases defined by a birth weight Z-score 
≤ -1.28. In order to reduce the risk of mixing normal and dysfunctional placentas, the 
results of placental pathological examinations were included. In 17 out of the 23 cases, 
placental examination revealed signs of PVM, whereas the remaining six placentas 
were normal, and therefore these six cases were excluded. As a part of the study 
protocol, placental pathological examination was also performed in 31 of the 68 
normal pregnancies. In four of these, signs of PVM was demonstrated and 
consequently, those were excluded. Thus, 64 normal pregnancies and 17 cases 
remained in the study for further analysis. 
 
4.3. METHODS 
4.3.1. STUDY I–V: ULTRASOUND EXAMINATION 
At the time of MRI (+/- 1 day), an ultrasound examination was performed using a 
Voluson E10 ultrasound system (GE Healthcare, Kretz Ultrasound, Zipf. Austria). 
The examination included an EFW, measurement of the amniotic deepest vertical 
pocket and Doppler assessment of the UtA, UA and the MCA including the CPR. In 
cases with abnormal UA PI and MCA PI, the DV flow velocity was also assessed. 
The EFW was calculated based on the head circumference, abdominal circumference 
and femur length (243). The UtA PI was measured at the point where the UtA crosses 
the external iliac artery. The mean PI of the left and right UtA and the presence of 
diastolic notch was reported. The UA PI was measured in a free-floating mid-portion 
of the umbilical cord, and the MCA PI was obtained in the proximal section at the 
level of the circle of Willis. The DV flow velocity was assessed either in a mid-sagittal 
longitudinal plane of the fetal trunk or in an oblique transverse plane through the upper 
abdomen. 
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4.3.2. STUDY I-V: MRI EXAMINATION 
The placental MRI examinations were all performed in a GE Discovery MR450 1.5-
Tesla MRI System (GE Healthcare, Milwaukee,WI, USA). The pregnant women were 
placed in left lateral position in order to avoid aortocaval compressions by the uterus. 
Hearing protection was provided for the women and a cardiac receiver coil was placed 
on the abdomen, covering the uterus. Initially, T2-weighted localizer images in three 
planes were obtained in order to determine the anatomical position of the placenta. In 
order to obtain the placental imaging near the center of the magnet, the women was 
repositioned if the placenta was not located near the magnetic isocenter. From the 
localizer images, placement of placental slices was determined in order to obtain a 
transversal view of the placenta (Figure 12). This orientation of placental slices was 
used in all the MRI sequences in the MRI protocol. 
 
Figure 12. Placement of a placental slice. To the right: T2*-weighted image. Placenta marked 
in red. 
After the localizer images and slice set-up, the MRI acquisition was performed 
according to the protocol as illustrated in Figure 13. A FIESTA sequence (Fast 
Imaging Employing Steady-state Acquisition) and a diffusion-weighted MRI (DWI) 
were obtained for other studies not reported in this thesis. The average scan time was 
35 minutes, which was well tolerated by the women. In a minor subset of the women, 
the BOLD sequence and T2* map during oxygen-challenge were not performed due 
to time constraints.  
 
Figure 13. The MRI acquisition protocol.   
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T2* acquisition (Study I, IV-V) 
Placental T2* measurements were performed using a multi-echo GRE sequence with 
the following parameters: TR = 70.9ms; 16 echoes ranging from 3.0 to 67.5ms in steps 
of 4.3ms; flip-angel 30°, field of view, 350×350 mm; and matrix, 256×128 mm. The 
size of the matrix resulted in an in-plane resolution of 1.37×2.73 mm. In Study I, two 
8 mm central placental slices with a slice gap of approximately 2 cm were obtained. 
As the reproducibility of the T2* values was increased by averaging the T2* values 
in each slice (Study I), the MRI protocol was changed, and thus three placental slices 
were obtained in Study IV-V.  Each slice was acquired in a single breath-hold of 12 
seconds during normoxia and during oxygen-challenge.  
 
BOLD MRI acquisition (Study II-III, V) 
The BOLD MRI was acquired using a dynamic single-echo GRE MRI sequence with 
the following parameters: TR = 8000 ms, TE = 50 ms, flip-angle = 90. Field-of-view 
of 36x36 cm with a matrix of 128x128 which resulted in an in plane spatial resolution 
of 3.6x3.6 mm. Multiple slices (thickness of 6 mm, no spacing) covering the entire 
uterus were obtained, thus the number of slices varied according to the size of the 
uterus. Each slice was repeated every eighth second.  
 
During the initial 5-minute BOLD MRI, the women breathed normoxic air. Then a 
non-rebreather facial mask (Hudson Respratoty Care, Durham, NC) was applied, 
while the women remained in the same position on the board, followed by medical 
oxygen challenge (100% O2) delivered at a flow rate of 12 L/min. In Study II, a 5-
minute oxygen-challenge was performed. However, these data indicated that this time 
period was too short in order to achieve steady state hyperoxic levels in some 
dysfunctional placentas. Therefore, the oxygen-challenge period was prolonged to 10 
minutes in the Study V.  
4.3.3. MRI ANALYSIS 
The MRI Dicom data were processed using an in-house developed program written 
in MatLab (The MathWorks Inc., Natick, MA, USA). 
 
T2* analysis (Study I, IV-V) 
In each placental slice, a ROI covering the entire placenta was drawn and the placental 
T2* values were estimated from the mean signal intensities within the placental ROI 
as a function of echo time using a non-linear least squares fitting algorithm (Figure 
14). 
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Figure 14. The T2* analysis (244) 
The T2* value was reported as the mean of the acquired placental slices. In case of 
placental susceptibility artefacts (Figure 15), the T2* dataset was excluded.  
 
Figure 15. Placental T2*-weighted images at TE 30. To the left: no placental artefacts, 
placenta marked in grey. To the right: severe susceptibility artefact (dark blurring) covering 
a large part of the placenta (marked in red).  
In Study I, the reproducibility of the T2* method was assessed including repeat T2* 
measurements as described in the Chapter 4.2. In that study, we also assessed the inter-
observer reproducibility of the ROI drawings as the ROIs were drawn by two 
independent observers. Furthermore, we investigated the variation of T2* values 
between two parallel placental slices.  
In Study V, changes in placental T2* values during oxygen-challenge (∆T2*) were 
estimated and used in the interpretation of the oxygen-challenge ∆BOLD response. 
The ∆T2* was estimated as: 
∆T2* = T2*hyperoxic – T2*baseline (3) 
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Other T2* MRI analysis methods were investigated (unpublished). As the placenta 
has varying fractions of maternal and fetal compartments, we considered if division 
of the MRI ROI into two layers, would improve the accuracy. However, in these T2*-
weighted images, often it was difficult to distinguish between the two compartments, 
especially in dysfunctional placentas and in early normal pregnancy. Thus, we 
experienced that separate ROIs reduced the accuracy of the method. Furthermore, we 
considered calculation of T2* as an average of the ROI based on pixel by pixel T2*. 
However, we experienced that low signal-to-noise ratio as well as minor movements 
made these calculations less accurate as compared to the T2* value based on the signal 
average of the ROI.   
BOLD MRI analysis (Study II, III, V) 
Placenta BOLD signal was investigated in three placental slices evenly distributed in 
the placenta. Within each slice, a ROI covering the entire placenta was drawn. In each 
frame, this ROI was adjusted in order to correct for maternal movements including 
uterine contractions ensuring that the placental borders were not crossed. BOLD 
signal (mean of the three slices) versus time curves were made. As discussed in 
Chapter 2.3.2, the absolute BOLD signal cannot be compared between individuals. 
Therefore, we then normalized the BOLD signal using a 2-3 minute normoxic steady 
state BOLD signal levels (Sbaseline):   
Normalized BOLD Signal (X) = Sx/Sbaseline x 100% (4) 
In case of a uterine contraction reducing the BOLD signal during the normoxic period, 
the steady state level was defined from a steady state time interval prior to or after the 
contraction. Normalized BOLD signal versus time curves were then created (mean of 
the three slices), and the oxygen-challenge steady state level was defined as a 2-3 
minute steady state level during the final 5-minute oxygen-challenge. The relative 
change in BOLD signal (∆BOLD response) was then calculated as 
∆BOLD response = (Shyperoxic – Sbaseline) / Sbaseline x 100%  (5) 
In case of uterine contractions preventing estimation of normoxic or hyperoxic steady 
state levels (steady state period < 1 minute), the BOLD dataset was excluded.  
In Study III, only the initial 5-minute normoxic BOLD MRI was analyzed. Using 
equation (4), we created normalized placenta BOLD signal versus time curves (mean 
of the three slices). Moreover, we assessed the MR images regarding changes in the 
uterine shape and placental volume during the 5-minute MRI. Figure 16 illustrates the 
placental slices used for these analyses.  
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Figure 16. Slice placements during MRI. To the left: slices used for the assessment of placental 
area, placental BOLD signal and uterine area. To the right: examples of ROIs onto BOLD MR 
images: a) placental area ROI, b) placental BOLD signal ROI, c) uterine area ROI (245) 
In order to assess changes in the uterine shape and placental volume during the MRI 
scan, we used a manual segmentation method. In the 56 MRI scans, ROIs were drawn 
covering the outer border of the uterus and the placenta. In each frame, the ROIs were 
manually adjusted in order to correct for movements. The area of the ROI could then 
be estimated by the number and size of the pixels within the ROIs. In the placenta, 
three ROIs (one central and two peripherally, Figure 16) were assessed enabling an 
estimation of changes in placental volume rather than placental area. Due to time-
constraints, only one central slice was used in the assessment of changes in the uterine 
shape. Time curves of the normalized BOLD signal and pixel numbers within the 
uterine and the placental ROIs were then created in order to investigate the timely 
relation between changes in the three figures. 
In Study V, the relative changes in BOLD signal during oxygen-challenge was 
interpreted using the T2* measurements based on the following approximation:  
∆BOLD response ≈ ∆T2* / T2*baseline (6) 
4.3.4. PLACENTAL PATHOLOGICAL EXAMINATION 
The original project protocol did not include placental pathological examination in 
uncomplicated pregnancies, as pathological examination in these pregnancies is not a 
part of our routine practice. Thus, in Study I-III placental pathological examination 
was only performed in pregnancies complicated by placental dysfunction. However, 
during the project period, the protocol was changed, thereby also including placental 
pathological examination in the uncomplicated pregnancies. Thus, in Study IV and V, 
placental pathological examination was also performed in a large proportion of the 
uncomplicated pregnancies. An experienced placental pathologist, who was blinded 
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to any MRI results but not to the clinical information, performed the examinations. 
They were performed according to the standard protocol described in Chapter 2.2.1 
including standard sections taken for microscopy (85). Placental trimmed weights 
were measured after removing the membranes, the umbilical cord and excessive blood 
(246). In the studies in this thesis, only pathological signs of PVM, defined as signs 
of MVM and/or FVM (85), were reported. 
 
4.4. STATISTICAL ANALYSIS IN STUDY I-V 
In each study, the assumptions behind the statistical tests were assessed, including the 
distributions of variables, which were examined using probability plots and Shapiro-
Wilk test. Gestational age-adjusted Z-scores of MRI variables were calculated by 
subtracting the expected MRI value from the measured value and divided by the 
standard deviation at the given time in gestation.  The statistical software package 
Stata®14 (StataCorp LP, College Station, TX, USA) was used for the data analysis. 
P-values < 0.05 were considered statistically significant. 
Study I 
In the 24 normal pregnancies, the association between placental T2* and gestational 
age was examined using a regression analysis. From this model, the T2* values of the 
four cases were converted into Z-scores. The inter-observer reproducibility, the T2* 
variation between two parallel placental slices, and the reproducibility of repeat 
measurements were investigated using Bland Altman plots. 
Study II 
In each of the 25 pregnancies, the significance of the increase in BOLD signal was 
tested using a paired t test. In the normal group (n = 21), the mean ∆BOLD response 
was estimated (mean ± SD).  
Study III 
In the uterine contraction study, the significance of a reduction in normalized placenta 
BOLD signal was tested against the steady state BOLD signal level using a paired t 
test. We defined the maximum reduction in BOLD signal as the lowest measured 
signal value. Likewise, we tested the maximum reductions in the number of pixels in 
the uterine and placental ROIs against the steady state levels, defining the maximum 
reductions as the lowest measured number of pixels within the ROIs. The mean timely 
delay between changes in the three figures were also assessed (mean ± SD).  
 
Study IV 
Placental T2* values were converted into gestational age-adjusted Z-scores using the 
T2* regression model obtained in Study I. The associations between Z-scores of birth 
weight, placental T2* and UtA PI were investigated using linear regression models. 
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The performance of T2* and UtA PI in prediction of low birth weight were assessed 
and compared using receiver operating characteristics curve (ROC) analyses (247).  
 
Study V 
In the normal pregnancies, the associations between the ∆BOLD response and T2* 
figures and gestational age were assessed using linear regression analysis, and from 
the obtained regression models, the MRI figures were converted into gestational age-
adjusted Z-scores. The mean Z-score values of the MRI figures were compared 
between groups using a Student’s t test or unequal variance t test. Among all the 
pregnancies, the ∆BOLD response was not normally distributed, and therefore this 
figure was logarithmically transformed which achieved normality. We then 
investigated the association between the logarithmically transformed ∆BOLD 
response (Log10BOLD) and normoxic T2* value using a regression analysis. 
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CHAPTER 5. SUMMARY OF RESULTS 
In the following section, a summary of main results in each study is presented. 
Detailed descriptions of results are available in the published papers. 
5.1. STUDY I 
In this T2* study, the 24 normal pregnancies were all clinically uneventful and had 
normal neonatal outcomes including birth weight Z-score > -2.0, and gross placental 
findings were normal. In the four cases, birth weight Z-scores were below -2.0. In the 
three cases with abnormal Doppler findings, placental pathological examination 
revealed signs of PVM, whereas no signs of PVM were demonstrated in the fourth 
case (further description of the four cases are available in Table 1, Paper I).  
In normal pregnancies, a significant positive linear association between placental T2* 
and gestational age was observed (r = 0.83, p < 0.001), with a reduction in placental 
T2* of 4.6 ms per gestational week (Figure 17). In the three cases with abnormal 
Doppler findings and placenta pathological signs of PVM, the placental T2* Z-scores 
were significantly lower (Z-scores < -3.8), whereas the T2* Z-score in the fourth case 
with normal Doppler flows and no signs of PVM, was normal (Z-score of – 0.34). 
 
Figure 17. The linear relation between placental T2* (mean of two slices) and gestational week. 
Thick line is ordinary least squares fit (P < 0.001. R2 = 0.68). Dotted lines indicate 95% 
confidence interval while dashed lines indicate 95% prediction interval (244).   
The reproducibility assessment of the method, investigated in the normal pregnancies, 
revealed 95% limits of agreement for the within- and between-session variation for a 
single slice of -2.1 ± 10.4ms and -0.6 ± 22.6ms, respectively. For the mean value of 
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two slices, the agreements were -1.1 ± 7.0ms and -0.0 ± 17.8ms. The agreement 
between two paralleled placental slices was -1.1 ± 17ms (Bland Altman plots 
illustrated in Figure 3, Paper I) and the inter-observer agreements of the ROI drawings 
were -0.1 ± 4.6ms. 
 
5.2. STUDY II  
In this BOLD study, the 21 normal pregnancies were all clinically uneventful and had 
normal neonatal outcomes including normal birth weights and normal gross placental 
findings. Case 1 with abnormal Doppler flows, including an increased DV PI, resulted 
in still birth at 26 weeks’ gestation. Case 2 and 3 with abnormal UA and MCA Doppler 
findings resulted in acute cesarean section at 29 and 31 weeks’ gestation due to fetal 
distress. In case 4, with the normal Doppler findings, an elective cesarean section was 
performed in gestational week 34 due to a very small EFW of -39%. Placental 
pathological examination demonstrated signs of PVM in case 1, 2 and 3, whereas no 
signs of PVM were demonstrated in case 4. In the four cases, birth weight Z-score 
was < -2.0.  (Further description of the four cases are available in Table 1, Paper II). 
In each of the 21 normal pregnancies, we observed a significant increase in the BOLD 
signal during oxygen-challenge. In this group, the mean ∆BOLD response was 12.6 ± 
5.4%, p < 0.0001. Figure 18 illustrates the differences in placental BOLD signal 
during normoxia and hyperoxia. During oxygen-challenge, the placenta appeared 
brighter and more homogenous.  
 
Figure 18. Placenta BOLD MR images in a normal pregnancy at 36 weeks’ gestation. Cross-
section through the central part of the placenta during normoxia (left) and during maternal 
oxygen-challenge (right). Placenta marked with white arrows. 
In the four cases, opposing BOLD results were demonstrated (Figure 19). In case 1, 
with the increased DV PI, we could not demonstrate a significant increase in the 
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BOLD signal during the oxygen challenge (∆BOLD response of 0.1%). In case 2 and 
3, we observed very high ∆BOLD responses of 26.8% and 29.5%, respectively. In 
case 4, with the normal Doppler findings, the ∆BOLD response was 13.4%. 
 
Figure 19. The mean ∆BOLD response in 21 normal pregnancies and the ∆BOLD response 
in each of the four cases (248). 
 
5.3. STUDY III 
Spontaneous uterine contractions were observed in eight out the 56 5-minute BOLD 
MRIs (14.2%). These eight pregnancies were between 23 and 37 weeks’ gestation at 
the time of MRI. During the contractions, the BOLD signal was significantly reduced 
by 17 ± 5%. This was clearly visible in the MRI scan as the placenta appeared darker. 
In each case, the reduction in BOLD signal was preceded by a remarkably change in 
the uterine shape, which could be assessed by a reduction of the number of pixels 
within the uterine ROI area of 8 ± 2%. The mean duration of the contraction was 189  
± 66 seconds. During the contractions, we also observed a reduced placental area in 
the three separate slices, as assessed by a reduced number of pixels within in the ROI 
of the slices of 17 ± 7%. Figure 20 illustrates these main three observations during a 
uterine contraction. 
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Figure 20. T2*-weighted images during uterine relaxation (a) and uterine contraction (b). 
Placenta marked with white arrows. During the contraction, the placenta is darker and the 
uterine and placental areas are reduced (245).  
In the eight uterine contractions, the manual segmentation revealed a significant 
temporal delay between the change in the uterine shape, the reduction in placental 
volume and in the reduction of BOLD signal (illustrated in Figure 21).  
 
Figure 21. The timeline of changes in normalized BOLD signal (blue line) and changes in the 
number of pixels within the uterine (green line) and the placental ROIs (yellow line) in a uterine 
contraction (245) 
In the remaining 48 BOLD MRI scans, we observed no remarkably change in the 
uterine shape followed by reductions in the BOLD signal.  
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5.4. STUDY IV 
Of the 100 pregnancies originally included in this T2* study, three uncomplicated 
pregnancies were excluded because of placental susceptibility artifacts, leaving 97 
pregnancies for further analysis. Fifteen of these 97 pregnancies (15%) resulted in a 
neonate with a birth weight Z-score ≤ 2.0.  
The study demonstrated significant associations between Z-scores of placental T2* 
and UtA PI (r = -0.56, p < 0.0001), birth weight and T2* (r = 0.68, p < 0.0001), and 
birth weight and UtA PI (r = -0.43, p < 0.0001), (Figure 22). 
 
Figure 22. The associations between Z-scores of placental T2* and UtA PI (left), birth weight 
and T2* (middle) and birth weight and UtA PI (right). Black lines present ordinary least 
squares fits, dashed lines 95% prediction intervals. Black hollow circles represent the normal 
pregnancies. Black closed circles represent neonates with low birth weight (249) 
The ROC analysis revealed a significant higher performance of the T2* value (AUC 
= 0.92, 95% CI, 0.85-0.98) than the UtA PI (AUC = 0.74; 95% CI, 0.60-0.89) in the 
prediction of low birth weight (p = 0.010). The performance was not improved by 
combining the two methods (p = 0.438). The optimal Z-score T2* cut-off in detecting 
low birth weight was -1.3. Using this cut-of, the sensitivity and specificity of the T2* 
method were 93% (95% CI, 68-100) and 80 % (95 CI, 73-90), respectively. Likewise, 
the optimal UtA PI cut-off was 0.7 with a sensitivity of 60% (95% CI, 32-84) and 
specificity of 87% (95% CI, 77-93). The distribution of cases at the T2* Z-score cut-
off of -1.3 and birth weight Z-score cut-off of -2.0 is illustrated in Figure 23.  
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Figure 23. The distribution of cases: FP, false positive; TN, true negatives; TP, true positive; 
FN false negative. Vertical red line represents the estimated optimal T2* Z-score cut-off value 
of -1.3. Horizontal red line represent the birth weight Z-score cut-off of -2. Closed circles 
representing low birth weight, open circles normal birth weight. The association between Z-
scores of placental T2* and birth weight is illustrated. Black line presents ordinary least 
squares fit, dashed lines 95% prediction intervals. 
Placental pathological examination was performed in 57 out of the 97 pregnancies. 
The examinations revealed signs of MVM and/or FVM in 13 out of 14 cases with low 
T2* value and low birth weight (“true positives”, TP), and in 8 out 11 examined cases 
with low T2* value but normal birth weight (“false positive”, FP). Furthermore, signs 
of PVM were demonstrated in 6 out of 32 examined pregnancies with normal T2* 
value as well as normal birth weight (“true negatives”, TN). In the remaining 
examined pregnancies, including the single case with normal T2* value and low birth 
weight (“false negative”, FN), no signs of PVM were revealed. The results of the 
placental pathological examination are further highlighted in Figure 24.  
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Figure 24. Results of placental pathological examination: signs of PVM (black closed circles), 
normal examination (black open circles), no examination (gray open circles dots). Vertical red 
line represents the estimated optimal T2* Z-score cut-off value of -1.3. Horizontal red line 
represent the birth weight Z-score cut-off of -2.0. FP, false positive; FN, false negative. The 
association between Z-scores of placental T2* and birth weight is illustrated. Black line 
presents ordinary least squares fit, dashed lines 95% prediction intervals. 
The 14 TP cases were all clinical complicated pregnancies with clinical signs of 
placental dysfunction including abnormal Doppler ultrasound findings and/or 
abnormal CTG and/or abnormal biophysical profile. Likewise, most of the FP cases 
had clinical signs of placental dysfunction, whereas the TN cases and the single FN 
case showed no such signs. One of the six TN cases with placental signs of PVM, 
however, delivered spontaneously at 33 weeks’ gestation. (Further characteristics of 
each pregnancy including the major placental pathological findings are presented in 
Table 2 and in Supplementary Data in Paper IV). 
 
5.5. STUDY V 
Of the 64 normal pregnancies and 17 cases complicated by placental dysfunction, 16 
were excluded due to uterine contraction preventing estimation of steady state BOLD 
signal levels (12 normal pregnancies, 4 cases). Figure 25 presents a BOLD signal 
curve from such an excluded pregnancy. Furthermore, three normal pregnancies were 
excluded due to placental susceptibility artefact. Thus, 62 pregnancies remained in the 
study for further analyses (49 normal pregnancies at 15 – 41 weeks’ gestation at MRI 
and 13 cases at 22 – 37 week’s gestation at MRI). Four of the 13 cases had an increased 
UA PI at the time of MRI. 
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Figure 25. BOLD signal versus time plot from a MRI scan complicated by a placental uterine 
contraction. 
In the normal group, there was a significantly positive linear association between the 
∆BOLD response and gestational age (r = 0.81, p < 0.0001) and in the group of cases, 
the ∆BOLD response was significantly higher (median Z-score = 4.94, p = 0.0001; 
Figure 26).  
 
Figure 26. The association between placental ∆BOLD response and gestational age in normal 
pregnancies (open circles). Black line indicate the least square fit, dashed lines indicate 95% 
prediction interval. Black closed circles indicate the 13 cases. 
 
Figure 27 presents the BOLD signal curve from a normal pregnancy and a case, both 
at 32 weeks’ gestation. 
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Figure 27. Normalized BOLD signal intensity curves in a normal pregnancy (left) and in a 
pregnancy complicated by placental dysfunction (right). GA, gestational age. 
  
The results of the T2* measurements are illustrated in Figure 28. In the normal group, 
there was a significantly negative linear association between gestational age and 
baseline T2* (r = -0.90, p < 0.0001). In the case group, baseline T2* (mean Z-score = 
-3.13) was significantly lower when compared to normal group (p < 0.0001). In the 
normal group, the absolute ∆T2* was increased with gestational age (r = 0.47, p = 
0.0009), whereas ∆T2* did not differ between groups (p = 0.37).    
 
 
Figure 28. The association between placental T2* measurements and gestational age in normal 
pregnancies (open circles). Black lines indicate least square fit, dashed lines indicate 95% 
prediction interval (PI). Left: Baseline T2*. Middle: Hyperoxic T2* (baseline T2* least square 
fit and 95% PI superimposed on the graph). Right: ∆T2*. Black closed circles indicate the 13 
cases complicated by placental dysfunction.  
In the 62 pregnancies, there was a strong linear association between Log10 ∆BOLD 
and normoxic T2* (r = -0.88, p < 0.0001), (Figure 29). 
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Figure 29. The association between Log10 ∆BOLD and normoxic T2*. Black line 
indicates least square fit, dashed lines indicate 95% prediction interval (PI). Open circles, 
normal pregnancies; closed circles, cases.   
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CHAPTER 6. DISCUSSION 
This chapter contains a detailed discussion of each of the five studies, including 
methodological considerations as well as general discussions of the placenta T2* 
value and the placenta ∆BOLD response when relevant. Furthermore, at the end, the 
chapter contains a short discussion of some general aspects of the studies. 
6.1. STUDY I  
In this study, we assessed the reproducibility of the placental T2* measurements and 
we investigated the T2* value in 24 normal pregnancies and in 4 FGR cases.  
A limitation of this study was the very few cases, in which however, placental 
pathological examination was performed. Moreover, placental pathological 
examination was not performed in the normal pregnancies, and in theory, some of 
these might have had abnormal placental findings. Nonetheless, these pregnancies 
were clinical uneventful with normal Doppler findings, normal birth weights at term 
(Z-score > -2.0), and normal gross placental findings, indicating normal placental 
function. 
The assessment of the within session, between sessions and inter-observer 
reproducibility showed the T2* method to be reasonable robust. Averaging two slices 
improved the reproducibility, which most likely reflects the heterogeneous nature of 
the placenta. Based on this observation, we recommend averaging of two or more 
slices in future studies.  
In the 24 normal pregnancies, the T2* value was reduced as gestational age advanced. 
This can be explained by reduced placental oxygenation within both the intervillous 
blood and the fetoplacental blood as demonstrated by previous invasive studies 
(44,48). Nonetheless, the maturation of the normal placenta, including the continuous 
development of the trophoblast throughout gestation and the deposition of fibrin, may 
reduce the intrinsic T2 relaxation (178,250,251) and thereby reduce the placental T2* 
value. From our data it is not possible to assess which of these parameters contribute 
the most to the reduced T2* value. Moreover, changes in placental blood volume 
fraction (the ratio of vascular volume to total placental volume) could affect the 
intrinsic T2 value. However, this fraction seems to be constant throughout gestation 
(252).  Our findings are in contrast to a study by Huen et al. (199) who could not 
demonstrate any correlation between placental T2* and gestational age in 14 
uncomplicated pregnancies at 23 to 37 weeks’ gestation. One explanation might be 
that we used a higher number of echo-times at a wider range, which may have 
improved our T2* fits. Moreover, our findings are in accordance with previous MRI 
studies demonstrating reduced placental T2 values (250,251) and reduced placental 
perfusion fractions (75,76) as gestational advances.  
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In the case with normal Doppler findings and normal placental pathological findings, 
the T2* value was normal, indicating that this fetus was SGA but not growth 
restricted. In the three cases with abnormal Doppler findings and placental 
pathological signs of PVM, the T2* values were markedly lower. Thus, these fetuses 
were small for date due to placental dysfunction. The low T2* value may be explained 
by placental hypoxia and abnormal tissue morphology associated to placental 
dysfunction. As discussed in Chapter 2.2, it is well known that the sO2 of the 
fetoplacental blood may be reduced in placental dysfunction (82,107,108); however, 
controversies exist regarding the sO2 of the maternal blood. In addition to placental 
hypoxia, placental morphological changes such as infarction and fibrosis may reduce 
the intrinsic T2 relaxation (253) and thereby the T2* value. Previous studies have 
demonstrated lower placental T2 values in FGR pregnancies (74,251,254). Moreover, 
changes in blood volume fractions in the dysfunctional placenta might affect the T2* 
value. However, opposing results are presented in the literature regarding the blood 
volume fractions in dysfunctional placentas (93,252). Thus, as the ROIs covered the 
entire placenta in transverse section, the low T2* value may reflect abnormal placental 
morphology, low sO2 of maternal blood as well as low sO2 of the fetoplacental blood. 
Which of these parameters contributes the most to the low T2* value, cannot be 
elucidated from our data. Even so, for the purpose of a diagnostic test of placental 
dysfunction, this distinction may not be of clinical interest.   
 
6.2. STUDY II  
In this study, we investigated the ∆BOLD response in 21 normal pregnancies and in 
4 FGR cases. 
Limitations of the study were the same as discussed in Study I regarding the small 
number of cases and lack of placental pathological examination in the normal 
pregnancies. In addition, we did not assess the reproducibility of the ∆BOLD response 
including assessment of inter-observer variation of the ROI drawings. 
In each of the 21 normal pregnancies, we observed a significant increase in placenta 
BOLD signal (mean of 12.6 ± 5.4%) during the 5-minute oxygen-challenge. This 
finding was in accordance with a previous study by Sorensen et al. (59), in which they 
demonstrated a mean ∆BOLD response of 15.2 ± 3.2% in 8 uncomplicated 
pregnancies at the same mean gestational age. The interpretation of the increased 
BOLD signal is complex. In the following, the origin of the changes in BOLD signal 
is discussed, including sO2 changes and the potential contributions from changes in 
blood flow and blood volume during oxygen-challenge.  
Changes in placental BOLD signal during oxygen-challenge may reflect changes in 
maternal and fetoplacental blood sO2, as discussed in Chapter 2.3.2. The MRI ROIs 
were drawn in cross sections of the placental, thereby containing both maternal and 
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fetal blood compartments. In order to assess the separate contribution from each of 
these compartments, separate ROIs should have been drawn. Nevertheless, as 
previously described, we experienced such separation of the two compartments to be 
very challenging in the BOLD MRI image. Therefore, in order to assess the relative 
contributions from these blood compartments, the in vivo ratio of maternal versus 
fetal blood volume in the placental ROI should be considered. Previous postpartum 
morphometric analysis studies have estimated the ratio of maternal versus fetal blood 
volume within the placenta to be around 4:1 at term (93,255,256). In vivo, the 
intrauterine total placental volume as assessed by MRI has been estimated to be 
around 450 ml at 27 week’s gestation (257,258) and 1000 ml (258,259) near term. In 
contrast, the postpartum placental volume has been estimated to be only around 250 
ml at 23-31 weeks’ gestation (40) and 450 ml at term (40,256). Thus, a large 
proportion of the in vivo placental volume consists of maternal and fetal blood. In 
vivo, the total amount of blood in the fetoplacental circulation is about 110 ml/kg fetal 
weight (260). At 30 week’s gestation, nearly half of the fetoplacental blood volume is 
within the placenta (261), whereas at term, one third of the blood volume is within the 
placenta (260). Thus at term, if 15 ml umbilical cord blood is subtracted (260), the in 
vivo placenta contains approximately 100 ml fetal blood at a fetal weight of 3000 g. 
From these estimates, an approximation of the in vivo amount of maternal blood in 
the intervillous space at term is around 450 ml (1000 ml subtracted by 450 ml + 100 
ml) given the assumption that the postpartum placental volume is blood empty. Thus 
at term, the in vivo ratio of maternal versus fetal blood volume within the placenta 
may be at least 4:1, which is in accordance with the postpartum estimates. Thereby, 
when considering this in vivo ratio, maternal blood may be a larger contributor to 
changes in BOLD signal than the fetoplacental blood.  
Nonetheless, in addition to the in vivo blood volume ratio, the normoxic sO2 of the 
maternal and fetoplacental blood should also be considered in the assessment of the 
contribution to BOLD signal changes. As the maternal arterial blood entering the 
intervillous space is almost fully saturated during normoxia, only the binding of 
additional oxygen within the maternal venous blood in the periphery of the 
intervillous space contributes to the increase in BOLD signal during oxygen-
challenge. On the contrary, during normoxia, the entire fetoplacental blood volume is 
low-saturated and therefore during oxygen-challenge, the entire fetoplacental blood 
volume may contribute to the BOLD signal changes. These considerations are well in 
line with the observed changes in the BOLD MR image. During normoxia (Figure 18, 
left), the placenta in cross-section appears rather heterogeneous with several regional 
areas with high signal intensity centrally and low signal intensities peripherally and 
towards the fetal site of the placenta. These areas most likely represent the placental 
lobes containing the intervillous space and the villous three protruding from the 
chorion plate, with high-saturated maternal arterial blood centrally (high BOLD signal 
intensity) and low-saturated venous blood peripherally and towards the fetoplacental 
side (low BOLD signal intensity). This interpretation of the BOLD image is supported 
by a study by Schabel et al, who demonstrated that local maxima in T2* maps were 
strongly correlated with entering spiral arteries identified using DCE MRI in the 
rhesus macaque (58). During oxygen-challenge (Figure 18, right), the placenta 
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appears more homogeneous as the signal intensity in the darker areas increases, 
reflecting an increased saturation of the maternal venous blood and the fetoplacental 
blood. Thus, the increased BOLD signal during oxygen-challenge may reflect 
increased sO2 of the maternal venous blood as well as the placental oxygen transport 
from the mother to the fetus (188). The distinction between maternal and fetal blood 
contributions cannot be further elucidated from our data. 
In addition to changes in blood sO2 during oxygen-challenge, changes in placental 
blood perfusion and blood volume should be considered as both of these parameters 
may affect the amount of deoxyhemoglobin within a voxel and thereby the BOLD 
signal. The potential vasocontrictory effects of oxygen might reduce the placental 
blood flow during maternal oxygen-challenge. This remains to be investigated; 
however, using MRI arterial spin labelling, preliminary data from the thesis by Huen 
(262) indicated that changes in placental perfusion during oxygen-challenge is sparse. 
Therefore, placenta BOLD signal changes observed during oxygen-challenge most 
likely primary reflects changes in sO2. Moreover, in a previous study using a rat brain 
model, Kennan et al (183) presented a model for separating the effects of changes in 
blood volume and blood oxygenation during respiratory challenges (hyperoxia and 
hypoxia). They demonstrated that during respiratory challenge, the BOLD signal 
change is dominated by changes in blood oxygenation rather than changes in regional 
blood volume. This is accordance with the well-described close correlation between 
BOLD signal changes and changes in tissue oxygenation as demonstrated by previous 
invasive studies (179,180,263). 
In the four cases, divergent ∆BOLD responses were observed. In case number 4, the 
∆BOLD response was normal, thereby indicating normal placental function. This 
BOLD finding was in accordance with the normal Doppler findings and the normal 
placental pathological findings in this case. This fetus was SGA, however, not growth 
restricted. In case 2 and 3 (with abnormal UA and MCA Doppler findings and 
placental signs of PVM), we observed a ∆BOLD hyper-response. As the ∆BOLD 
response can only be assessed in relative values, this hyper-response may be explained 
by 1) altered baseline conditions, including a lower baseline oxygenation and 
abnormal placental morphology, reducing the baseline signal, and/or 2) an increased 
absolute oxygenation during oxygen-challenge compared to normal. Previously, it has 
been demonstrated that baseline oxygenation in cerebral MRI studies is a significant 
modulator of the ∆BOLD response, in which lower baseline oxygenation is associated 
with a higher ∆BOLD response (176). Baseline oxygenation of the placenta may have 
the same effect on the placental ∆BOLD response. This hypothesis is further 
elaborated on in the discussion of Study V. In the remaining case number 1 (in which 
even the DV flow velocity was abnormal and placental examination revealed signs of 
PVM), we observed no significant increase in BOLD signal during the 5-minute 
oxygen-challenge. This finding may reflect a severely impaired placental oxygen 
transport capacity in line with the “non-responder” theory as proposed by Arduini et 
al. (237) and Nicolaides et al.(190). Nonetheless, we speculate that the BOLD signal 
may have increased during prolonged oxygen-challenge as we observed a small - yet 
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insignificant - increase in BOLD signal towards the end of the 5-minute oxygen-
challenge (Figure 19). For this reasons, the oxygen-challenge was prolonged from 5 
to 10 minutes in Study V. Furthermore, in the dynamic BOLD MRI and in the BOLD 
signal intensity curve, signs of a uterine contraction starting prior to the oxygen-
challenge was observed, which may have biased the BOLD result. The presence of 
uterine contractions during BOLD MRI and their effect on the BOLD signal is 
discussed in Study III.   
 
6.3. STUDY III  
In this study, we investigated the presence of spontaneous reductions in placental 
BOLD signal during dynamic BOLD MRI in 56 normal pregnancies. Spontaneous 
reduction in BOLD signal was observed in eight out of these pregnancies at a broad 
range of gestations. As each case was preceded by a change in the uterine shape, which 
was only observed in these cases, we suggest that the reductions in BOLD signal are 
due to spontaneous uterine contractions.  
This study had limitations. Firstly, considerations regarding the lack of placental 
pathological examination are the same as discussed in Study I. Another limitation was 
the lack of contraction intensity registrations. Nonetheless, the use of intrauterine 
pressure assessment during these MRI scans would never be an option in our setting. 
The women were informed to report if they felt spontaneous uterine contractions 
during the MRI acquisition, but none of them did and therefore, we assume that the 
observed contractions were generally low-intensity contractions. Moreover, a 
limitation of the study was that we did not assess intra- or interobserver reproducibility 
of the ROI drawings due to time constraints. However, in collaboration with Health 
Science and Technology, Aalborg University, methods for automatic segmentations 
of the uterus are being developed, and the results of an unpublished pilot study were 
highly in accordance with the manual segmentations. 
We observed a temporal association between the uterine contraction, the reduction in 
placental volume and the reduction in placental oxygenation (Figure 21). At the very 
beginning of the contraction, the placental volume and oxygenation are unaffected. 
However, within approx. 30 seconds, the placental volume and placental oxygenation 
start to decrease. During uterine relaxation, the placental volume and placental 
oxygenation slowly recover, notable the placental oxygenation fully recovers later 
than the placental volume.     
The interpretation of the observed reductions in placenta BOLD signal is complex as 
several factors may affect the signal. These factors include changes in placental blood 
flows, blood volumes and fetal oxygen extraction as described below. 
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The temporal delay between the beginning of the contraction and the reduction in 
placental volume and placental oxygenation may represent a gradual increased 
resistance in the spiral arteries and thereby an impaired uteroplacental blood flow. 
This increased resistance may be caused by the contracting myometrium and/or the 
increased intrauterine pressure. The finding is in accordance with previous Doppler 
ultrasound studies, which have also revealed this temporal association between the 
UtA blood flow velocities and provoked uterine contractions (264) and between the 
UtA blood flow velocities and Braxton Hicks contractions (265) with increasing 
resistance of the uterine arteries during contraction. This impaired uteroplacental 
blood flow reduces the BOLD signal. On the contrary, several studies have 
demonstrated that fetoplacental circulation during uterine contractions is unaffected 
in normal pregnancies. This may be explained by that, the increased intrauterine 
pressure is transmitted equally to the umbilical vein and arteries without changes in 
blood flow, or that an increased fetal preload enables the uncompromised fetus to 
maintain a constant fetoplacental blood flow (266-268).    
Changes in blood volumes during contractions may also affect the BOLD signal. We 
observed a reduced placental volume during the contractions. Thus, this finding 
suggests that during low amplitude uterine contractions, the maternal blood is 
squeezed out of the intervillous space like a sponge. If so, the ratio between well-
oxygenated maternal and low-oxygenated fetal blood within the placental MRI ROI 
is decreased. This may contribute to the observed reduction in placental BOLD signal 
during uterine contractions. The observed reduction in placental blood volume is in 
conflict with a previous study by Bleker et al (269). In that study, using ultrasound, a 
distention of the intervillous space during labor contraction was suggested, thereby 
indicating initial venous obstruction, leaving more maternal blood available for 
exchange with the fetal compartment during contraction. However, the contractions 
investigated by Bleker et al were labor contractions, which may explain the opposing 
results.  
Increased fetal oxygen extraction may also contribute to the reduction in BOLD 
signal. This is supported by the slower recovery of placental oxygenation compared 
to the recovery of placental volume (Figure 21), which was observed in each of the 
eight contractions. The slower recovery of placental oxygenation may be explained as 
follows: During a uterine contraction, maternal blood is squeezed out of the 
intervillous space reducing the maternal blood volume in the placenta. Therefore, 
increased oxygen extraction occurs in order to avoid fetal hypoxia as described in 
previous studies (187). During uterine relaxation, the blood volume is regained, and 
the delayed recovery of the BOLD signal may represent a gradually washout of 
intervillous blood, from which the increased oxygen extraction has occurred. Thus, 
due to this delay between the recovery of the placental volume and the placental 
BOLD signal, our data indicate that during uterine contractions, the BOLD signal is 
reduced not only because of impaired uteroplacental blood flow and reduced maternal 
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blood volume, but also because of an increased oxygen extraction, and thereby a 
reduced sO2 within the intervillous blood. 
This study demonstrates that the presence of uterine contractions needs to be 
considered when interpreting placental MRI results. In placental BOLD MRI, a 
uterine contraction during oxygen-challenge may lead to an underestimation of the 
∆BOLD response. 
 
6.4. STUDY IV 
In this study, we investigated the association between placental T2* measurements, 
UtA PI and birth weight, and we compared the performance of the T2* with the UtA 
PI in the prediction of low birth weight. Significantly associations were revealed 
between birth weight and both T2* and UtA PI as well as between T2* and UtA PI. 
The study indicated that T2* may be a strong predictor of low birth weight and it 
performed significantly better than the UtA. Furthermore, the T2* values were closely 
related to the presence of pathological signs of PVM. 
One major limitation of this study was the mixed population regarding the risk of low 
birth weight. Thus, relevant predictive values of the T2* measurements could not be 
estimated. The mixed population was chosen in order to increase the number of low 
birth weight infants, as the incidence of low birth weight in our population is only 
around 3%.  Nonetheless, the mixed population did not prevent comparison of the T2* 
and UtA PI. Moreover, a major limitation was that we did not perform a cross-
validation of our data. Thus, the performance of placental T2* in the prediction of low 
birth weight should be validated in a larger clinical cohort study with randomly 
division of the data into training and validation sets. 
A strength of the study was that placental pathological examination was performed in 
a large subset of the pregnancies. The results of the examinations were highly in 
accordance with the measured T2* values. Interestingly, the only false negative case 
(normal T2*, low birth weight) revealed no signs of PVM which was in accordance 
with the lack of clinical signs of placental dysfunction during pregnancy. Moreover, 
in 8 out of 11 examined false positive cases (low T2*, normal birth weight), 
pathological signs of PVM were revealed. This was also well in line with the presence 
of clinical signs of placental dysfunction during pregnancy. These results of the 
placental pathological examinations highlight the limitations in using low birth weight 
as a freestanding marker of placental dysfunction as described in Chapter 2.2.4.  
In this study, we observed a negative association between the T2* measurements and 
the UtA PI, which may be explained by a lower placental sO2 when the placental 
perfusion is impaired. Moreover, as discussed in Study I, morphological changes 
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associated to placental dysfunction, including changes in placental blood fractions, 
may contribute to the observed association. This is supported by a study by Derwig et 
al. (254), who demonstrated significant associations between placental T2 and UtA 
PI. Our data indicated that the T2* method performed significantly better than the 
UtA PI in the prediction of low birth weight. The low T2* value in cases with 
pathology only on the fetoplacental site, may contribute to the higher performance of 
the T2* method as the UtA PI only estimates the placental vasculature on the maternal 
site. Another explanation may be a higher reproducibility of the T2* than the UtA PI. 
In the latter, rather poor intra- and interobserver reproducibilities have been 
demonstrated (140).  In our study, specialists in fetal medicine performed the UtA PI 
measurements, and the performance was comparable to previous studies (141-
144,146). 
 
6.5. STUDY V 
In this study, we aimed to interpret the relative ∆BOLD response in normal 
pregnancies and in those complicated by placental dysfunction by using placental T2* 
measurements. 
A strength of this study was that we included the results of placental pathological 
examinations in the distinction between normal pregnancies and those complicated by 
placental dysfunction. Thereby, we reduced the risk of mixing normal and 
dysfunctional placentas. The pathological examination, however, was not performed 
in a subset of the normal pregnancies, yet these were clinical uneventful with normal 
gross placental examination. Another strength was the exclusion of pregnancies in 
which uterine contractions interfered with the estimation of steady state BOLD signal 
levels, which could have biased the results as described in Study III. 
In the 49 normal pregnancies, we observed an increasing ∆BOLD response as 
gestational age advances. The T2* findings indicated that this can be explained by a 
combination of a reduced baseline T2* and an increasing hyper-oxygenation (∆T2*). 
The reduced T2* value may represent the well-described decline in placental 
oxygenation within the maternal and the fetoplacental blood as well as morphological 
maturation of the placenta throughout gestation as discussed in Study I. The increasing 
∆T2* may be explained by the decline in placental sO2 throughout gestation, leaving 
more of the additional oxygen during oxygen-challenge to be bound in later 
gestations. Moreover, an increased placental blood volume fraction within the 
placental ROI throughout gestation would increase the ∆T2*, although previous 
studies suggest the placental blood volume fraction to stay relatively constant 
throughout gestation (252,270).   
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In the group of 13 cases, the ∆BOLD response was significantly higher compared to 
normal. In these pregnancies, the baseline T2* value was significantly lower, whereas 
the absolute change in placental oxygenation (∆T2*) during oxygen-challenge did not 
differ from normal. The low baseline T2* value may represent reduced oxygenation 
within the maternal and/or fetoplacental blood as well as abnormal placental 
morphology, as described in Study I. These placental morphological abnormalities, 
including a lower placental blood volume fraction (93), may prevent the average 
hyperoxic T2* value to reach normal levels during oxygen-challenge (Figure 28, 
middle). This may explain why the ∆T2* did not differ from the normal pregnancies, 
and thereby it may illustrate the baseline intrinsic T2 effect on the T2* value. Thus, 
in the dysfunctional placenta, the high ∆BOLD response is caused merely by altered 
baseline conditions (reduced baseline T2*) rather than an absolute increase in 
placental oxygenation (∆T2*). This is also supported by the strong negative 
association between baseline T2* and the oxygen-challenge ∆BOLD response; and 
our findings are in accordance with a previous cerebral BOLD MRI study 
demonstrating that baseline oxygenation modulates the cerebral ∆BOLD response 
(176). Thus, according to our results, the placenta baseline state modulates the 
hyperoxic ∆BOLD amplitude.  
As the ∆T2* did not differ between the two groups, one could speculate whether the 
oxygen environment in dysfunctional placentas differs from normal and whether the 
low baseline T2* value simple reflects morphological abnormalities within the 
dysfunctional placenta. Nonetheless, it is well documented that the fetoplacental 
blood sO2 is reduced in pregnancies complicated by placental dysfunction 
(82,107,108). As the ROIs covered the entire placenta, this reduced fetoplacental sO2 
would contribute to the low placental T2* values, at least in the cases with abnormal 
UA Doppler. Nonetheless, whether the maternal blood within the intervillous space is 
hypoxic or not cannot be elucidated from our data. 
The pathophysiological explanation of the slow response observed in some of the 
dysfunctional placentas (as illustrated in Figure 27) is unclear. One explanation may 
be that the simple diffusion across the villous membrane is impaired in the 
dysfunctional placentas. Thus, oxygenation of the fetoplacental blood during the 
oxygen-challenge is delayed compared to normal. Another explanation may be an 
impaired perfusion in the intervillous space, including hypoperfused local areas (8), 
and thereby a slow replacement of relatively low-saturated maternal blood within 
these areas. This latter explanation is in accordance with the previous placental study 
by Brunelli et al. (118) using DCE MRI as described in Chapter 2.2.3. In that study, 
they demonstrated significant intervillous hypoperfusion and many patchy 
underperfused areas in pregnancies complicated by placental dysfunction, 
representing the different degrees of occlusion within the spiral arteries (39). In our 
study, we did not assess the ∆BOLD variation between placental slices, which may 
be higher in cases compared to normal. In order to elaborate on the slow response in 
our BOLD MRIs, the ∆BOLD response should be correlated to the results of the 
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placental pathological findings, as the response rate might differ between placentas 
with signs of MVM and those with signs of FVM. 
Because of the placental “non-responder” observed in Study II, the oxygen-challenge 
was prolonged from 5 to 10 minutes in the current study. The prolonged oxygen-
challenge may explain why we did not observe any cases with a ∆BOLD hypo-
response in this study. Even thought that the oxygen-challenge was prolonged, in 
several dysfunctional placentas, we observed that the steady state level was not reach 
until the final minutes during the 10-minute oxygen-challenge. In some of these cases, 
one could even speculate whether the hyperoxic steady state level was reached (as in 
the case illustrated in Figure 27). Thus, we might have underestimated the ∆BOLD 
response. The observed ∆BOLD hyper-response is in conflict with two studies in rat 
FGR models, in which low ∆BOLD/∆T2* responses were observed in placentas 
within the ligated horn (196,197). The opposing results may be due to differences in 
rat FGR models and human FGR pregnancies, or a too short oxygen-challenge in the 
rat studies. Nonetheless, further human placenta BOLD studies in severe 
dysfunctional placentas are needed in order to assess whether placental “non-
responders” exist.  
 
6.6. GENERAL ASPECTS 
Placental ROIs 
As described in the method section, placental ROIs covered the entire placenta in 
transverse section. Thus, the ROIs contained both the maternal and the fetal blood 
compartments. We used this method, as we experienced that it was extremely 
challenging to distinguish between the two compartments in the MR images. Thereby, 
as mentioned above, our data were limited in terms of the interpretations of the T2* 
values and BOLD responses. As the trophoblast protrudes into the intervillous space, 
complete separation of the two compartments using MRI is challenging. Methods to 
be used may include DCE MRI but for safety reasons in human pregnancies, this is 
not possible in most settings. Other MRI sequences and post-processing tools might 
be useful in the distinction between the two placental compartments.  
Low birth weight as a proxy of placental dysfunction 
In this project, we used low birth as a proxy of placental dysfunction. As previously 
described, this estimate is not a perfect marker of placental dysfunction as not all FGR 
neonates are SGA and not all SGA neonates are FGR. Therefore, a major strength of 
this project was that placental pathological examination was performed in the FGR 
cases (Study I, II, IV, V) and in a large subset of the normal pregnancies (Study IV and 
V). Although, placental pathological findings may be present in normal pregnancies 
and absent in some pathological pregnancies, in theory we thereby improved the 
diagnosis of “true” placental dysfunction. Study IV highlighted the issue of using low 
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birth weight as a freestanding marker of placental dysfunction as several false positive 
cases (normal birth weight, low T2* value) exhibited clinical and placental 
pathological signs of placental dysfunction. The T2* value was indeed in accordance 
with the results of placental pathological examinations regardless of the birth weight. 
In general, the studies could have been improved if placental pathological 
examination had been performed in all the pregnancies. Even after the updated 
protocol, unfortunately, not all placentas in the uncomplicated pregnancies were 
collected post-partum. Thus, in some of the uncomplicated pregnancies, placental 
pathological examination might have revealed abnormal findings. This could in 
particular have been the case in study I-IV, in which we defined normal birth weight 
by a Z-score > -2. In study V, we defined normal birth weight by a Z-score > - 1.28 
and therefore, in that study it was more unlikely that the “normal” neonates had 
suffered from placental dysfunction.  
Subgroup analyses 
In Study I-II and IV-V, subgroup analysis based on the placental pathological findings 
of MVM and/or FVM may have revealed interesting differences in ∆BOLD response 
and T2* values. Likewise, subgroup analysis of early-onset versus late-onset placental 
disease should be elaborated on due to the potential different placental phenotypes as 
described in Chapter 2.2.1. Preeclampsia was present in a small number (two) of our 
cases, and subgroup analysis may reveal interesting MRI differences between cases 
with and without preeclampsia. Moreover, subgroup analysis based on Doppler 
findings should be examined. Because of the small sample sizes of pregnancies 
complicated by placental dysfunction, such subgroup analyses were not performed in 
this project.  
Placental MRI bias 
In this project, we focused on two types of placental MRI bias that could potentially 
interfere with the MRI results, namely placental susceptibility artefacts, as discussed 
in Chapter 2.3.2, and the presence of spontaneous uterine contractions as discussed in 
Study III.  
 
The presence of placental susceptibility artefacts was a minor problem in this project 
and the artefacts only excluded very few participants. Several actions were done in 
order to prevent the occurrence of these artefacts. Firstly, we used a 1.5 T system 
rather than a 3T system. Secondly, we aimed to place the placenta, as isocentric within 
the MRI scanner as possible, were the magnetic field is most homogenous. Moreover, 
we used a maximum TE of 67.5 ms during the T2* acquisition. In addition, prior to 
the MRI scan, we carefully evaluated the participants clothing etc. in order to remove 
any magnetic material. 
 
The presence of uterine contraction during the BOLD scans was a major problem as 
they often interfered with the estimation of the steady state BOLD signal levels and 
therefore, they excluded rather many participants. Nonetheless, they were often 
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clearly visible during the dynamic BOLD MRI scans. This is in contrast to uterine 
contractions during the rather static T2* acquisitions, during which it was not possible 
to assess the characteristic dynamic changes in the shape of the uterus and the placenta 
as well as characteristic changes in placental signal. A uterine contraction during the 
T2* acquisition may reduce the T2* value thereby creating false positive results. MRI-
compatible tocography might be used in order to detect the uterine contractions; 
however, it remains to be investigated whether such equipment would be able to detect 
these low-amplitude contractions. Rather instead, the T2* acquisition could be 
repeated during the MRI session, and then the highest mean should be reported.   
73 
CHAPTER 7. CONCLUSIONS 
The overall conclusion of this thesis is that placental T2*-weighted imaging can be 
used as a non-invasively method to detect placental hypoxia and thereby placental 
dysfunction.  
The conclusions of each of the five studies are as follows: 
Study I  
 Placental T2* measurements are reproducible between MRI sessions and the 
reproducibility can be further improved by averaging two placental slices.  
 In normal pregnancies, the placental T2* value is reduced as gestational age 
advances.  
 In pregnancies complicated by placental dysfunction, the T2* value is 
significantly lower. 
Study II  
 During 5-minute oxygen-challenge, the placenta BOLD signal is increased 
in normal pregnancies.  
 In pregnancies complicated by placental dysfunction, the ∆BOLD response 
is altered; in pregnancies with mild/moderate placental dysfunction, the 
∆BOLD response is higher than normal, while the response might be absent 
in case of severe placental dysfunction (“non-responder”).  
Study III  
 Subclinical uterine contractions occur frequently throughout pregnancy and 
they markedly reduce placental oxygenation.  
 Spontaneous subclinical uterine contractions need to be considered when 
interpreting placental MRI as these contractions may interfere with the MRI 
results. 
Study IV  
 Placental T2* may be used as a predictor of low birth weight. In this study, 
it performed significantly better than the UtA PI.  
 Placental T2* is closely related to placental pathological findings. 
Study V  
 In normal pregnancies, the ∆BOLD response increases as gestational age 
advances. 
 In pregnancies complicated by placental dysfunction, the ∆BOLD response 
is higher than normal.  
 The ∆BOLD hyper-response is caused merely by altered baseline conditions, 
including a lower baseline oxygenation and altered placental morphology. 
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CHAPTER 8. PERSPECTIVES AND 
FUTURE WORK 
8.1. THE FUTURE MRI PROTOCOL 
The overall purpose of this project was to investigate the feasibility of T2*-weighted 
Magnetic Resonance Imaging (MRI) as a non-invasive method for detection of 
placental hypoxia and thereby placental dysfunction. It was concluded that both the 
BOLD method as well as the T2* method were able to detect placental dysfunction. 
However, in Study V, we concluded that both methods estimate placental baseline 
conditions. Therefore, one should consider whether the MRI protocol should include 
both methods in future works. For this purpose, strength and limitations of each 
method need to be considered as well as their performance in the prediction of low 
birth weight. 
Strengths and limitations of the BOLD and the T2* methods  
Strengths of the T2* method are the very short acquisition time (12 sec. per slice) and 
the simple and easy MRI analysis, which makes it suitable to be combined with other 
easy-obtained MRI biomarkers. Moreover, the reproducibility of the T2* 
measurements is acceptable, although between scanner reproducibility remains to be 
investigated. Limitations are the presence of susceptibility artefacts and spontaneous 
uterine contractions – both of which may reduce the T2* value creating false positive 
results. Strengths of the BOLD method is the dynamic assessment, which could be 
useful in the investigation of placental and/or fetal physiological phenomena. Major 
limitations of the BOLD method is the rather long acquisition time (15 minutes) in 
which even 10 minute of oxygen-challenge may not be enough in order to reach steady 
state level in some dysfunctional placental. If the BOLD signal does not reach the 
state-state level, the BOLD response is underestimated leading to a false negative 
result. Moreover, uterine contractions often interfere with the estimation of the steady 
state BOLD signal levels and this may also potentially lead to false negative results. 
The extremely time-consuming MRI analysis is also a major limitation of the BOLD 
method, and for this method ever to become a clinical tool, automatic placental 
segmentation tools need to be developed. Finally, the reproducibility of the BOLD 
methods remains to be investigated. The strengths and limitations of the two methods 
are summarized in Table 2. 
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 T2* BOLD 
+ Short acquisition time 
Short analysis time 
Reproducible 
Dynamic assessment of the placenta (and 
the fetus) 
Reproducibility? 
- Susceptibility artefacts → false positives 
Uterine contractions → false positives  
Long acquisition time 
Time-consuming MRI analysis 
Uterine contractions → false negatives 
Table 2. Strengths and limitations of the T2* method and in the BOLD method. 
The performance of the BOLD and T2* methods in detecting low birth weight. 
In an unpublished study, we have investigated and compared the performance of each 
methods in detecting low birth weight. This was in a mixed population of 104 
pregnancies, in which 1/3 had an EFW < - 15% at the time of MRI. The primary 
outcome was low birth weight (Z-score < - 2.0). Twenty pregnancies were excluded 
due to uterine contractions preventing estimation of steady state BOLD signal levels, 
leaving 84 pregnancies in the study for further analysis. Eleven of these 84 
pregnancies resulted in a neonate with low birth weight. The performance in the 
prediction of low birth weight did not differ statistically between the BOLD and the 
T2* method, although there was a trend towards a higher performance of the T2* 
method (BOLD AUC = 0.82 versus T2* AUC of 0.90, p = 0.157). Combining the 
methods did not improve the performance compared to the T2* performance.  
In conclusion, given the strengths and limitation of each methods and the test 
performances as illustrated above, the oxygen-challenge BOLD sequence could be 
excluded from the placental MRI protocol.  
 
8.2. THE CLINICAL PERSPECTIVE 
The clinical perspective of T2*-weighted imaging is a none-invasive in-vivo test of 
placental dysfunction. Nonetheless, clinical implementation would depend on several 
factors. The cost and availability of MRI scanners would be a limiting factor in most 
centers. For this reason, MRI may only be used in selected cases; however, the 
question is which cases should be selected? According to our local data, 66% of 
pregnant women attend for at least one ultrasound EFW scan after 24 weeks’ 
gestation. In 19% of these women, the EFW is below -15% and thereby they are 
considered at risk of FGR and receive additional scans throughout pregnancy. 
However, in our population, less than 3% of all singletons are born with low birth 
weight. Thus, a clinical implication of the T2* method in our setting could be in the 
risk-stratification of pregnancies with an EFW < -15%. For this purpose, the 
performance of the T2* method in a population of pregnancies with an EFW < -15% 
should be investigated. The perspective would be a reduced number of late second 
and third trimester scans as pregnancies with normal placental T2* need no further 
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controls. This would lead to more attention on the true high-risk fetuses suffering from 
placental dysfunction. Nonetheless, as not all FGR fetuses are SGA, other markers 
could be included in order to decide whom to scan. Such markers could be the 
maternal characteristics, the UtA PI or angiogenetic factors – depending on the 
surveillance program in the center. The T2* performance in such high-risk 
populations should be investigated, although one should keep in mind that a large 
proportion of adverse outcomes including low birth weight occurs within the low-risk 
population.  
 
8.3. FUTURE WORK 
Several aspects of the T2* method need to be further investigated. In this project, we 
investigated the reproducibility between MRI sessions; however, the reproducibility 
between different MRI scanners needs to be assessed. Longitudinal studies of the 
placental T2* values should also be conducted in order to examine the development 
of the T2* value within the same pregnancy. Moreover, the relation between the T2* 
value and time to delivery should be investigated as the T2* value might provide 
predictive information on delivery day, which would be of high clinical interest. 
Likewise, other adverse outcome measurements could be included in future studies. 
Furthermore, as previous mentioned, the correlation between placental T2* values and 
specific placental pathological findings, Doppler findings and gestational age at 
disease onset (early versus late onset) should be elaborated on.  
The performance of the T2* method in combination with other easy-obtained 
placental MRI biomarkers should also be examined. Such MRI biomarkers could 
include the T2/T2*-ratio and the T1 relaxation time, the latter being sensitive to tissue 
pO2 levels. In our MRI protocol, we included a multi-slice 2D FIESTA and a DWI 
sequence. From these sequences, the placental volume, the ADC map and/or the 
perfusion fraction can be obtained, and they could be other MRI biomarkers to be 
combined with the T2* value. In addition to a clinical perspective of these combined 
MRI biomarkers, they could also be applied in future animal and human FGR studies 
in order to assess intervention effects directly within the placenta. 
Various MRI techniques are continuously being developed and technical improved, 
and they provide us new tools to be used in the understanding and the in vivo 
assessment of placental function.  
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